<html>
<body>
<H2>
Msx homeobox genes inhibit differentiation through upregulation of <I>cyclin D1</I>
</H2>

<STRONG>
</NOBR><NOBR>Gezhi Hu<SUP>1</SUP><SUP>,2</SUP></NOBR>, 
<NOBR>Hansol Lee<SUP>1</SUP><SUP>,2</SUP></NOBR>, 
<NOBR>Sandy M. Price<SUP>1</SUP><SUP>,3</SUP></NOBR>, 
<NOBR>Michael M. Shen<SUP>1</SUP><SUP>,3</SUP></NOBR> and 
<NOBR>Cory Abate-Shen<SUP>1</SUP><SUP>,2</SUP><SUP>,*</SUP></NOBR>
</STRONG><P>
<FONT SIZE=-1>
<SUP>1</SUP> Center for Advanced Biotechnology and Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA<BR>
<SUP>2</SUP> Department of Neuroscience and Cell Biology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA<BR>
<SUP>3</SUP> Department of Pediatrics, UMDNJ&#150;Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
</FONT><P>

<FONT SIZE=-1>*Author for correspondence (e-mail: <span id="em0">abate{at}cabm.rutgers.edu</span><script type="text/javascript"><!--
 var u = "abate", d = "cabm.rutgers.edu"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>)</FONT><P>



<I>Accepted May  4, 2001</I>
<P><A NAME="ABS"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
SUMMARY
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>SUMMARY</FONT><BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">INTRODUCTION<BR></A>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">MATERIALS AND METHODS<BR></A>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS<BR></A>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>


<B>During development, patterning and morphogenesis of tissues<SUP> </SUP>are intimately coordinated through control of cellular proliferation<SUP> </SUP>and differentiation. We describe a mechanism by which vertebrate<SUP> </SUP>Msx homeobox genes inhibit cellular differentiation by regulation<SUP> </SUP>of the cell cycle. We show that misexpression of <I>Msx1</I> via retroviral<SUP> </SUP>gene transfer inhibits differentiation of multiple mesenchymal<SUP> </SUP>and epithelial progenitor cell types in culture. This activity<SUP> </SUP>of <I>Msx1</I> is associated with its ability to upregulate <I>cyclin<SUP> </SUP>D1</I> expression and Cdk4 activity, while <I>Msx1</I> has minimal effects<SUP> </SUP>on cellular proliferation. Transgenic mice that express <I>Msx1</I><SUP> </SUP>under the control of the mouse mammary tumor virus long terminal<SUP> </SUP>repeat (MMTV LTR) display impaired differentiation of the mammary<SUP> </SUP>epithelium during pregnancy, which is accompanied by elevated<SUP> </SUP>levels of <I>cyclin D1</I> expression. We propose that <I>Msx1</I> gene expression<SUP> </SUP>maintains <I>cyclin D1</I> expression and prevents exit from the cell<SUP> </SUP>cycle, thereby inhibiting terminal differentiation of progenitor<SUP> </SUP>cells. Our model provides a framework for reconciling the mutant<SUP> </SUP>phenotypes of Msx and other homeobox genes with their functions<SUP> </SUP>as regulators of cellular proliferation and differentiation<SUP> </SUP>during embryogenesis.</B><SUP> </SUP><P>



<P>Key words: Cell cycle, Differentiation, Proliferation, Homeobox genes, Transgenic mice, Mammary gland<P>
<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
INTRODUCTION
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>INTRODUCTION</FONT><BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">MATERIALS AND METHODS<BR></A>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS<BR></A>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

Homeobox genes are a large family of developmental regulatory<SUP> </SUP>genes that have diverse activities during embryogenesis. The<SUP> </SUP>biological functions of many homeobox genes have been elucidated<SUP> </SUP>through loss- and gain-of-function analyses, which have demonstrated<SUP> </SUP>their essential roles in controlling cellular proliferation<SUP> </SUP>and differentiation during development. However, the molecular<SUP> </SUP>mechanisms by which homeoproteins mediate these activities have<SUP> </SUP>not been examined extensively.<SUP> </SUP><P>

The vertebrate Msx homeobox gene family contains three members,<SUP> </SUP>two of which (<I>Msx1</I> and <I>Msx2</I>) have been well studied with respect<SUP> </SUP>to their expression patterns and biochemical properties (reviewed<SUP> </SUP>by <A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>; <A HREF="#DAVIDSON-1995">Davidson, 1995</A>). These genes<SUP> </SUP>encode closely related homeoproteins that function as transcriptional<SUP> </SUP>repressors through interactions with components of the core<SUP> </SUP>transcription complex as well as other homeoproteins (<A HREF="#CATRON-ETAL-1996">Catron et al., 1996</A>;<SUP> </SUP><A HREF="#CATRON-ETAL-1995">Catron et al., 1995</A>; <A HREF="#ZHANG-ETAL-1996">Zhang et al., 1996</A>; <A HREF="#ZHANG-ETAL-1997">Zhang et al., 1997</A>).<SUP> </SUP>Both <I>Msx1</I> and <I>Msx2</I> are expressed in overlapping<SUP> </SUP>spatial and temporal domains during development, in discrete<SUP> </SUP>regions of the facial primordia, limbs, neural tube and other<SUP> </SUP>embryonic regions (<A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>; <A HREF="#DAVIDSON-1995">Davidson, 1995</A>).<SUP> </SUP><P>

Although they are expressed in relatively diverse tissues, a<SUP> </SUP>common feature of Msx gene expression is its association with<SUP> </SUP>multipotent progenitor cells. For example, expression of <I>Msx1</I><SUP> </SUP>is robust in the progress zone of the limb bud, which corresponds<SUP> </SUP>to a region of highly proliferative, multipotential cells that<SUP> </SUP>give rise to chondrogenic and osteogenic derivatives of the<SUP> </SUP>limb. In contrast, <I>Msx1</I> is not expressed in the more proximal<SUP> </SUP>regions of the limb, where cells have ceased to proliferate<SUP> </SUP>and have begun to undergo differentiation (<A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>;<SUP> </SUP><A HREF="#DAVIDSON-1995">Davidson, 1995</A>). These, and other observations, have led<SUP> </SUP>to the hypothesis that Msx genes promote cellular proliferation,<SUP> </SUP>and that their expression is inversely correlated with differentiation<SUP> </SUP>(<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#DODIG-ETAL-1999">Dodig et al., 1999</A>; <A HREF="#MINA-ETAL-1996">Mina et al., 1996</A>;<SUP> </SUP><A HREF="#PAVLOVA-ETAL-1994">Pavlova et al., 1994</A>; <A HREF="#SONG-ETAL-1992">Song et al., 1992</A>; <A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>).<SUP> </SUP><P>

This model has garnered support from cell culture data, which<SUP> </SUP>have shown that forced expression of <I>Msx1</I> in myogenic precursors<SUP> </SUP>blocks their differentiation and represses expression of lineage<SUP> </SUP>specific genes, such as <I>MyoD</I> (<I>Myod1</I> &#150; Mouse Genome Informatics)<SUP> </SUP>(<A HREF="#SONG-ETAL-1992">Song et al., 1992</A>; <A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>). Moreover, ectopic<SUP> </SUP>expression of <I>Msx1</I> during chicken embryogenesis inhibits development<SUP> </SUP>of the limb musculature and represses <I>MyoD</I> expression in vivo<SUP> </SUP>(<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>). Msx genes have also been implicated<SUP> </SUP>as inhibitors of chondrogenic and osteogenic differentiation<SUP> </SUP>in culture (<A HREF="#DODIG-ETAL-1999">Dodig et al., 1999</A>; <A HREF="#MINA-ETAL-1996">Mina et al., 1996</A>), suggesting<SUP> </SUP>that these activities may not be limited to the myogenic lineage.<SUP> </SUP>Furthermore, the phenotypes of Msx loss- or gain-of-function<SUP> </SUP>mutations are also consistent with roles for Msx genes in regulating<SUP> </SUP>cellular proliferation and differentiation in vivo (<A HREF="#JABS-ETAL-1993">Jabs et al., 1993</A>;<SUP> </SUP><A HREF="#LIU-ETAL-1995">Liu et al., 1995</A>; <A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>; <A HREF="#SATOKATA-AND-MAAS-1994">Satokata and Maas, 1994</A>;<SUP> </SUP><A HREF="#WILKIE-ETAL-2000">Wilkie et al., 2000</A>; <A HREF="#WINOGRAD-ETAL-1997">Winograd et al., 1997</A>).<SUP> </SUP><P>

We have explored the mechanism(s) by which Msx genes, particularly<SUP> </SUP><I>Msx1</I>, function as negative regulators of differentiation. Using<SUP> </SUP>both cell culture and in vivo model systems, we demonstrate<SUP> </SUP>that <I>Msx1</I> inhibits the differentiation of multiple mesenchymal<SUP> </SUP>and epithelial cell types. This inhibition is associated with<SUP> </SUP>upregulation of <I>cyclin D1</I> (<I>Ccnd1</I> &#150; Mouse genome Informatics)<SUP> </SUP>expression as well as Cdk4 activity, while <I>Msx1</I> has minimal<SUP> </SUP>effects on cellular proliferation. Transgenic mice that overexpress<SUP> </SUP><I>Msx1</I> in the mammary gland display significant defects in epithelial<SUP> </SUP>differentiation during pregnancy, which are correlated with<SUP> </SUP>increased <I>cyclin D1</I> expression. We propose a model in which<SUP> </SUP><I>Msx1</I> prevents exit from the cell cycle by maintaining high levels<SUP> </SUP>of <I>cyclin D1</I> expression, thereby blocking terminal differentiation<SUP> </SUP>of progenitor cell populations.<SUP> </SUP><P>

<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
MATERIALS AND METHODS
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">INTRODUCTION<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>MATERIALS AND METHODS</FONT><BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS<BR></A>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG>Retroviral and transgenic expression plasmids</STRONG><BR>

Mammalian retroviruses were made in a derivative of <I>LZRSpBMN-Z</I><SUP> </SUP>(<A HREF="#KINSELLA-AND-NOLAN-1996">Kinsella and Nolan, 1996</A>) in which the <I>lacZ</I> gene was excised<SUP> </SUP>to make <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I>. Sequences corresponding to the coding region<SUP> </SUP>of <I>Msx1</I>, <I>Msx2</I>, a mutated <I>Msx1</I> derivative (<I>Msx1A</I>; <A HREF="#ZHANG-ETAL-1996">Zhang et al., 1996</A>),<SUP> </SUP><I>Hoxa7, Hoxc8, Dlx2</I> and <I>Dlx5</I> were subcloned as <I>Bam</I>HI-<I>Hin</I>dIII<SUP> </SUP>fragments into <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I>. Each contains an N-terminal Myc epitope,<SUP> </SUP>which allows for detection with an anti-Myc monoclonal antibody.<SUP> </SUP>Truncated <I>Msx1</I> genes<I>,</I> designated <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1</I>, <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">2</I> and <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">3</I>, correspond<SUP> </SUP>to amino acid sequences 2-270, 158-270 and 158-293, respectively.<SUP> </SUP>These were generated by PCR amplification and subcloned as <I>Bam</I>HI-<I>Hin</I>dIII<SUP> </SUP>fragments into <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I>. The <I>Msx1</I>-<I>estrogen receptor</I> fusion gene<SUP> </SUP>(<I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1-ER</I>) was generated using PCR amplification to join sequences<SUP> </SUP>corresponding to <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1(2-270)</I> with the amino acids 281-599 of<SUP> </SUP>the estrogen receptor tamoxifen mutant (MOR G525R) (<A HREF="#LITTLEWOOD-ETAL-1995">Littlewood et al., 1995</A>)<SUP> </SUP>and cloned into the <I>Bam</I>HI-<I>Hin</I>dIII sites of <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I>.<SUP> </SUP>The <I>cyclin D1</I> retrovirus was made by subcloning <I>pFLEX</I>-Flag-D1<SUP> </SUP>(<A HREF="#DIEHL-AND-SHERR-1997">Diehl and Sherr, 1997</A>) into <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I>. Avian retroviruses, <I>RCASBP(A)-Msx1</I><SUP> </SUP>and <I>RCASBP(A)-Msx1A</I>, were described (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#HU-ETAL-1998">Hu et al., 1998</A>).<SUP> </SUP>The transgenic plasmid, <I>MMTV</I>-<I>Msx1,</I> was made by<SUP> </SUP>cloning the full-length coding region of <I>Msx1</I> with Kozak sequences<SUP> </SUP>preserved into the <I>Hin</I>dIII site of the <I>MMTV-SV40-BSSK</I> (<A HREF="#STEWART-ETAL-1984">Stewart et al., 1984</A>).<SUP> </SUP>The complete sequences of all PCR-amplified constructs<SUP> </SUP>were confirmed. Expression of retrovirally expressed proteins<SUP> </SUP>was verified by western blot analysis using lysates from infected<SUP> </SUP>C2C12 cells (for mammalian retroviruses, <A HREF="#FIG3">Fig. 3</A>B and data not<SUP> </SUP>shown) or chicken embryonic fibroblasts (for avian retroviruses,<SUP> </SUP>data not shown).<SUP> </SUP><P>

<A NAME="FIG3"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG3"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=150 SRC="/content/vol128/issue12/images/small/DEV2657F3.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (82K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG3"
    onClick="startTarget('FIG3', 590, 530); this.href='/cgi/content-nw/full/128/12/2373/FIG3'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 3.</B> <I>Msx1</I> upregulates <I>cyclin D1</I> expression and Cdk4 activity. (A) C2C12 cells were infected with a control retrovirus (Vector) or retroviruses expressing Msx1 or cyclin D1 and grown under normal culture conditions (a, undifferentiated) or conditions that promote differentiation (b-d, differentiated). Scale bar: 0.1 mm. (B,C) Western blot analysis was performed using extracts prepared from C2C12 cells infected with a control retrovirus (Vector) or with retroviruses expressing Msx1 or Msx1A, followed by cell growth under normal culture conditions (undifferentiated) or conditions that promote differentiation (differentiated). The panels show whole-cell extracts probed with the indicated antibodies, except for panels labeled <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Cdk4 nuclear or <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Cdk2 nuclear, in which nuclear extracts were used. RNA polymerase II (<IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-RNA PolII) is a control for protein loading. (D) Cdk4 and Cdk2 kinase assays were performed using cell lysates from undifferentiated C2C12 cells or 293T cells infected with a control retrovirus (Vector) or those expressing Msx1 or Msx1A. The indicated kinases were immunoprecipitated using the corresponding antisera and kinase assays were performed using GST-Rb (amino acids 379-792) as substrate. Similar results were obtained using lysates prepared from differentiated C2C12 cells (data not shown).<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG>Retroviral gene transfer and differentiation assays</STRONG><BR>

Production of replication-competent avian retroviruses was described<SUP> </SUP>previously (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#HU-ETAL-1998">Hu et al., 1998</A>). Replication-defective<SUP> </SUP>mammalian retroviruses were made in Phoenix ecotropic retroviral<SUP> </SUP>packaging cells (ATCC) by transfection of the relevant <I>pLZRS<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0"></I><SUP> </SUP>plasmids using Lipofectamine Reagent (GIBCO-BRL). Viral supernatants<SUP> </SUP>were collected 24 hours after transfected cells reached confluence;<SUP> </SUP>4 &#181;g/ml polybrene was added to enhance infectivity. Target<SUP> </SUP>cells were seeded 1 day before infection at low density (1 <FONT FACE="ariel,helvetica">x</FONT><SUP> </SUP>10<SUP>4</SUP>/cm<SUP>2</SUP>) and infected with viral supernatants on two consecutive<SUP> </SUP>days at a multiplicity of infection of 20-50.<SUP> </SUP><P>

C2C12 cells were grown in Dublecco&#146;s Modified Eagle Medium<SUP> </SUP>(DMEM) supplemented with 20% fetal bovine serum (FBS). Myogenic<SUP> </SUP>differentiation was initiated by incubating confluent cells<SUP> </SUP>for 3 days in DMEM containing 2% horse serum and verified by<SUP> </SUP>visual detection of myotubes and by western blot analysis using<SUP> </SUP>an MHC antibody (see below). 10T1/2 cells (ATCC) were grown<SUP> </SUP>in Basal Medium Eagle (BME) supplemented with 15% FBS. Adipocyte<SUP> </SUP>differentiation was initiated by treatment with 3 &#181;M 5-azacytidine<SUP> </SUP>for 24 hours. After retroviral infection, confluent cells were<SUP> </SUP>treated with 1 &#181;M dexamethasone for 7 days.<SUP> </SUP><P>

Micromass assays were performed essentially as described (<A HREF="#AHRENS-ETAL-1977">Ahrens et al., 1977</A>).<SUP> </SUP>White Leghorn chicken eggs (SPAFAS) were incubated<SUP> </SUP>to stage 21-22 (<A HREF="#HAMBURGER-AND-HAMILTON-1951">Hamburger and Hamilton, 1951</A>). Forelimb buds<SUP> </SUP>were collected and digested with 0.1% trypsin-0.1% collagenase.<SUP> </SUP>10 &#181;l of digested cells (2<FONT FACE="ariel,helvetica">x</FONT>10<SUP>7</SUP> cells/ml) were infected<SUP> </SUP>with 1 &#181;l of concentrated avian retroviruses (<IMG SRC="/math/sim.gif" ALT="~" BORDER="0">10<SUP>9</SUP> cfu/ml)<SUP> </SUP>in growth media (F12/DMEM supplemented with 10% FBS) containing<SUP> </SUP>8 &#181;g/ml polybrene. Infected cells were incubated for 4<SUP> </SUP>days and differentiation was verified by staining with 0.5%<SUP> </SUP>Alcian Blue 8GX (pH 1). TMC23 cells (<A HREF="#XU-ETAL-1998">Xu et al., 1998</A>) were grown<SUP> </SUP>in DMEM supplemented with 10% FBS. Differentiation was initiated<SUP> </SUP>by treating confluent cells were with 50 &#181;g/ml ascorbic<SUP> </SUP>acid and 4 mM &#223;-glycerol phosphate for 16 days.<SUP> </SUP><P>

Chicken calvarial osteoblasts were prepared essentially as described<SUP> </SUP>(<A HREF="#GERSTENFELD-ETAL-1987">Gerstenfeld et al., 1987</A>). Eggs were incubated to stage 42<SUP> </SUP>(<A HREF="#HAMBURGER-AND-HAMILTON-1951">Hamburger and Hamilton, 1951</A>) after which the calvaria (skull<SUP> </SUP>bone) were digested with 0.25% trypsin-0.2% collagenase. Digested<SUP> </SUP>cells were plated at 5000 cells/cm<SUP>2</SUP> in <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Minimum Eagle media<SUP> </SUP>(<IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-MEM) supplemented with 10% FBS. Differentiation was initiated<SUP> </SUP>by addition of 100 &#181;g/ml ascorbic acid and 5 mM &#223;-glycerol<SUP> </SUP>phosphate for 16 days and verified by staining with Von Kossa&#146;s<SUP> </SUP>stain (silver staining). BMP2T3 calvarial cells (<A HREF="#GHOSH-CHOUDHURY-ETAL-1996">Ghosh-Choudhury et al., 1996</A>)<SUP> </SUP>were grown in <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">MEM supplemented with 7% FBS. Differentiation<SUP> </SUP>was initiated by treating confluent cells with 100 &#181;g/ml<SUP> </SUP>ascorbic acid and 5 mM &#223;-glycerol phosphate for 16<SUP> </SUP>days.<SUP> </SUP><P>

HC11 mammary epithelial cells (<A HREF="#HYNES-ETAL-1990">Hynes et al., 1990</A>) were grown<SUP> </SUP>in RPMI 1640 media supplemented with 10% FBS, 5 &#181;g/ml<SUP> </SUP>insulin and 10 ng/ml epidermal growth factor (EGF). Differentiation<SUP> </SUP>was initiated by removal of EGF for 3 days, followed by treatment<SUP> </SUP>with 10 &#181;M dexamethasone, 5 &#181;g/ml prolactin and<SUP> </SUP>5 &#181;g/ml insulin.<SUP> </SUP><P>

<STRONG>Expression analysis and probes</STRONG><BR>

Northern blot analysis was performed using mRNA (2.5 &#181;g<SUP> </SUP>per lane) prepared by the Poly(A)Pure mRNA purification kit<SUP> </SUP>(Ambion). Probes used for northern Blot analysis were labeled<SUP> </SUP>by StripEZ DNA labeling kit (Ambion) and are described in the<SUP> </SUP>text. Ribonuclease protection assays were performed as described<SUP> </SUP>(<A HREF="#SHEN-AND-LEDER-1992">Shen and Leder, 1992</A>) using total RNA prepared with Trizol<SUP> </SUP>RNA Isolation Reagent (GIBCO-BRL). The <I>Msx1</I> riboprobe corresponds<SUP> </SUP>to sequences encoding amino acids 1-57. The riboprobe for <I>&#223;-casein</I><SUP> </SUP>corresponds to sequences encoding amino acids 126 to 134. The<SUP> </SUP>rpL32 riboprobe has been described (<A HREF="#SHEN-AND-LEDER-1992">Shen and Leder, 1992</A>). Northern<SUP> </SUP>blot and ribonuclease protection assays were quantitated using<SUP> </SUP>a phosphorimager (Molecular Dynamics).<SUP> </SUP><P>

<STRONG>Western blot analysis, antibodies and kinase assays</STRONG><BR>

Western blot analysis was performed with an ECL-Plus chemiluminescence<SUP> </SUP>kit (Amersham Pharmacia Biotech) using the following antibodies:<SUP> </SUP>monoclonal antibody against myosin heavy chain (MF20) from Developmental<SUP> </SUP>Studies Hybridoma Bank; monoclonal antibody against murine cyclin<SUP> </SUP>D1 from Oncogene Sciences; polyclonal antisera against Cdk4<SUP> </SUP>and Cdk2 from Santa Cruz; and polyclonal antisera against RNA<SUP> </SUP>polymerase II small subunit band 7, a gift from Danny Reinberg.<SUP> </SUP>The monoclonal antibody directed against murine Msx1 was generated<SUP> </SUP>using the bacterially expressed full-length Msx1 protein as<SUP> </SUP>antigen. This antibody specifically recognizes an N-terminal<SUP> </SUP>epitope of the mouse Msx1 protein and does not crossreact with<SUP> </SUP>Msx2 (G. H. and C. A.-S., unpublished). Cdk4 and Cdk2 kinase<SUP> </SUP>assays were performed as described (<A HREF="#PARRY-ETAL-1999">Parry et al., 1999</A>). Cell<SUP> </SUP>lysates (500 &#181;g) were immunoprecipitated with 10 &#181;l<SUP> </SUP>of anti-Cdk4 or anti-Cdk2 antibody plus 10 &#181;l of protein-A/G<SUP> </SUP>agarose beads (Santa Cruz). Kinase assays were performed using<SUP> </SUP>GST<SUP>-</SUP>RB (amino acids 379-792, 0.5 &#181;g) as substrate.<SUP> </SUP><P>

<STRONG>Generation and analysis of MMTV-Msx1 transgenes</STRONG><BR>

Transgenic mice were generated as described (<A HREF="#STEWART-ETAL-1984">Stewart et al., 1984</A>)<SUP> </SUP>in FVB/N (Taconic Biotechnology) mice. Founders were identified<SUP> </SUP>by Southern blot analysis, using genomic DNA digested with <I>Bam</I>HI<SUP> </SUP>and an Msx1 cDNA probe; progeny were genotyped by PCR. Three<SUP> </SUP>independent transgenic lines were established; two lines expressed<SUP> </SUP>the <I>Msx1</I> transgene specifically in the mammary gland. Results<SUP> </SUP>shown are from one of these lines; the other line had a similar<SUP> </SUP>phenotype. No additional mammary epithelial abnormalities have<SUP> </SUP>been detected during 1 year of observation (data not shown).<SUP> </SUP><P>

For whole-mount and immunohistochemical analyses, mammary fat<SUP> </SUP>pads from virgin or pregnant transgenic female mice or littermate<SUP> </SUP>controls were dissected, spread onto glass slides, and fixed<SUP> </SUP>in 10% formalin; in each case the posterior fat pad (#4) was<SUP> </SUP>examined. For whole mounts, the mammary pads were stained with<SUP> </SUP>Hematoxylin. For immunohistochemistry, the formalin-fixed mammary<SUP> </SUP>pads were embedded in paraffin and adjacent sections were stained<SUP> </SUP>with either anti-Msx1 or anti-cyclin D1 antibodies (as above).<SUP> </SUP>Staining was performed using Vector M.O.M. Immunodection kit<SUP> </SUP>and Vector <I>NovaRED</I> substrate kit (Vector Laboratories). For<SUP> </SUP>ribonuclease protection analysis, total RNA was prepared (as<SUP> </SUP>above) from the anterior fat pad (#3).<SUP> </SUP><P>

<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
RESULTS
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">INTRODUCTION<BR></A>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">MATERIALS AND METHODS<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>RESULTS</FONT><BR>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG><I>Msx1</I> inhibits differentiation of multiple mesenchymal progenitor cell types</STRONG><BR>

To investigate the regulatory function of <I>Msx1</I> in cellular differentiation,<SUP> </SUP>we examined the consequences of its misexpression in progenitor<SUP> </SUP>cells that give rise to distinct mesenchymal lineages: muscle,<SUP> </SUP>fat, cartilage and bone (<A HREF="#FIG1">Fig. 1</A>). Our strategy was to introduce<SUP> </SUP>exogenous <I>Msx1</I> using retroviral gene transfer and then to assess<SUP> </SUP>differentiation, comparing the <I>Msx1-</I>infected cells with those<SUP> </SUP>infected with control retroviruses. To achieve high-level infectivity<SUP> </SUP>of mammalian cells, we used a derivative of the replication-defective<SUP> </SUP><I>pLZRS</I> retrovirus (<A HREF="#KINSELLA-AND-NOLAN-1996">Kinsella and Nolan, 1996</A>), while for avian<SUP> </SUP>cells we used a replication-competent <I>RCAS</I> retrovirus (<A HREF="#HUGHES-ETAL-1987">Hughes et al., 1987</A>).<SUP> </SUP>The percentage of <I>Msx1-</I>infected cells was monitored<SUP> </SUP>by immunofluorescence using an anti-<I>Msx1</I> antibody (see Materials<SUP> </SUP>and Methods), and in each case was greater than 80% (data not<SUP> </SUP>shown). As a control, we compared the activity of <I>Msx1</I> with<SUP> </SUP>a mutated derivative, <I>Msx1A</I>, which contains three amino acid<SUP> </SUP>substitutions in the N-terminal arm of the homeodomain (<A HREF="#ZHANG-ETAL-1996">Zhang et al., 1996</A>).<SUP> </SUP>The resulting Msx1A protein is stable and localizes<SUP> </SUP>to the nucleus (as does Msx1), but it is biochemically and biologically<SUP> </SUP>inert (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#HU-ETAL-1998">Hu et al., 1998</A>; <A HREF="#ZHANG-ETAL-1996">Zhang et al., 1996</A>;<SUP> </SUP><A HREF="#ZHANG-ETAL-1997">Zhang et al., 1997</A>).<SUP> </SUP><P>

<A NAME="FIG1"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG1"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=144 SRC="/content/vol128/issue12/images/small/DEV2657F1.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (111K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG1"
    onClick="startTarget('FIG1', 590, 517); this.href='/cgi/content-nw/full/128/12/2373/FIG1'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 1.</B> <I>Msx1</I> inhibits differentiation of multiple mesenchymal progenitor cell types. (A) C2C12 cells (a-d) or 10T1/2 cells (e-h) were infected with a control mammalian retrovirus (Vector) or retroviruses expressing Msx1 or Msx1A. Infected cells were grown under normal culture conditions (undifferentiated; a,e) or conditions that promote differentiation (differentiated; b-d,f-h) to myoctyes (b-d) or adipocytes (f-h). (B) Primary cultures of chicken limb chondrogenic cells (a-c) or calvarial osteogenic cells (e-g) were infected with a control avian retrovirus (Vector) or those expressing Msx1 or Msx1A. Differentiation is visualized by Alcian Blue staining (a-c) or silver staining (e-g). TMC23 chondrocytes (d) or BMP2T3 osteoblasts (h) were infected with a control mammalian retrovirus (Vector) or those expressing Msx1 or Msx1A followed by growth in conditions that promote differentiation. Alkaline phosphatase activity was measured from cell lysates; error bars show standard deviations of assays carried out in triplicate. (A,B) Representative data from experiments repeated a minimum of three times. Scale bars: 0.1 mm in A; 1 mm in B.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


As a model for muscle differentiation, we used a murine myoblast<SUP> </SUP>cell line, C2C12 (<A HREF="#YAFFE-AND-SAXEL-1977">Yaffe and Saxel, 1977</A>). These cells appear<SUP> </SUP>fibroblast-like under normal culture conditions, whereas in<SUP> </SUP>reduced serum they undergo terminal differentiation to elongated<SUP> </SUP>multinuclear myotubes (<A HREF="#FIG1">Fig. 1</A>A, compare a with b). Misexpression<SUP> </SUP>of <I>Msx1</I> by retroviral gene transfer blocked myogenic differentiation<SUP> </SUP>of the C2C12 cells whereas misexpression of <I>Msx1A</I> had no such<SUP> </SUP>effect (<A HREF="#FIG1">Fig. 1</A>A, compare c with d). Inhibition of myogenic differentiation<SUP> </SUP>by <I>Msx1</I> was also evident from the absence of myosin heavy chain<SUP> </SUP>(MHC) expression, a marker of terminal differentiation, in Western<SUP> </SUP>blots of cell lysates (see <A HREF="#FIG3">Fig. 3</A>B, top panel).<SUP> </SUP><P>

We observed a similar ability of <I>Msx1</I> to inhibit differentiation<SUP> </SUP>of adipocytes, chondrocytes and osteoblasts. In particular,<SUP> </SUP>misexpression of <I>Msx1</I> in 10T1/2 fibroblasts, which have the<SUP> </SUP>potential to undergo differentiation into multiple cell types,<SUP> </SUP>including adipocytes (<A HREF="#REZNIKOFF-ETAL-1973">Reznikoff et al., 1973</A>), resulted in a<SUP> </SUP>failure of the 10T1/2 cells to undergo adipogenesis, whereas<SUP> </SUP>overexpression of <I>Msx1A</I> had no significant effect (<A HREF="#FIG1">Fig. 1</A>A,<SUP> </SUP>e-h). In micromass explant assays, in which mesenchymal cells<SUP> </SUP>from chicken forelimb buds form chondrogenic nodules in culture<SUP> </SUP>(<A HREF="#AHRENS-ETAL-1977">Ahrens et al., 1977</A>), misexpression of <I>Msx1</I>, but not of <I>Msx1A</I>,<SUP> </SUP>significantly inhibited chondrogenesis as evident by reduced<SUP> </SUP>Alcian Blue staining (<A HREF="#FIG1">Fig. 1</A>B, a-c). Similarly, misexpression<SUP> </SUP>of <I>Msx1,</I> but not of <I>Msx1A</I>, resulted in a <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">sevenfold inhibition<SUP> </SUP>of chondrocyte differentiation in a murine chondrocyte cell<SUP> </SUP>line, TMC23 (<A HREF="#XU-ETAL-1998">Xu et al., 1998</A>) (<A HREF="#FIG1">Fig. 1</A>B, d). Finally, <I>Msx1</I>, but<SUP> </SUP>not <I>Msx1A</I>, inhibited osteogenesis in chicken calvarial osteoblasts<SUP> </SUP>(<A HREF="#FIG1">Fig. 1</A>B, e-g) as well as in a murine calvarial cell line, BMP2T3<SUP> </SUP>(<A HREF="#GHOSH-CHOUDHURY-ETAL-1996">Ghosh-Choudhury et al., 1996</A>) (<A HREF="#FIG1">Fig. 1</A>B, h). In summary, we<SUP> </SUP>have found that <I>Msx1</I> expression is incompatible with differentiation<SUP> </SUP>of multiple mesenchymal lineages, including muscle, fat, cartilage<SUP> </SUP>and bone, which confirms and extend previous findings (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>;<SUP> </SUP><A HREF="#DODIG-ETAL-1999">Dodig et al., 1999</A>; <A HREF="#MINA-ETAL-1996">Mina et al., 1996</A>; <A HREF="#SONG-ETAL-1992">Song et al., 1992</A>;<SUP> </SUP><A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>).<SUP> </SUP><P>

In contrast to its potent effect on differentiation, misexpression<SUP> </SUP>of <I>Msx1</I> had a minimal effect (10-20% activation) on cellular<SUP> </SUP>proliferation of embryonic fibroblasts or various other cell<SUP> </SUP>types (<A HREF="#FIG2">Fig. 2</A>A; data not shown). This observation was unexpected<SUP> </SUP>as Msx genes have been thought to promote cellular proliferation,<SUP> </SUP>based on their expression in proliferating cells in vivo (reviewed<SUP> </SUP>in <A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>). Taken together, we conclude that <I>Msx1</I><SUP> </SUP>is a potent inhibitor of cellular differentiation for multiple<SUP> </SUP>mesenchymal lineages, but does not significantly promote cellular<SUP> </SUP>proliferation.<SUP> </SUP><P>

<A NAME="FIG2"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG2"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=134 SRC="/content/vol128/issue12/images/small/DEV2657F2.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (44K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG2"
    onClick="startTarget('FIG2', 590, 494); this.href='/cgi/content-nw/full/128/12/2373/FIG2'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 2.</B> <I>Msx1</I> does not promote cellular proliferation, but alters the expression of cell cycle regulators. (A) Proliferation assays were performed using chicken embryonic fibroblasts infected with a control retrovirus (Vector) or one expressing Msx1. Cells were plated at low density in media containing the indicated percentage of fetal bovine serum. Cell number was estimated by measuring the optical density of Napthal blue-black stained cells and is expressed as percent of the control; error bars indicate standard deviation of assays performed in triplicate. Shown are representative data from assays repeated a minimum of five times. (B) Northern blot analyses were performed using mRNA prepared from undifferentiated C2C12 cells that had been infected with a control retrovirus (Vector) or retroviruses expressing Msx1 or Msx1A. Northern blots contained 2.5 &#181;g of mRNA per lane, and were probed with the indicated cDNAs and visualized by autoradiography. Northern blots were performed a minimum of two times using mRNA prepared from independent experiments; representative data are shown. RPL32 is a control for RNA loading.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG><I>Msx1</I> upregulates <I>cyclin D1</I> expression and Cdk4 activity</STRONG><BR>

Given its activity as a general inhibitor of mesenchymal cell<SUP> </SUP>differentiation, we anticipated that downstream effectors for<I><SUP> </SUP>Msx1 </I>are likely to include widely expressed regulatory genes<SUP> </SUP>in addition to lineage-restricted genes such as<I> MyoD </I>(<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>;<SUP> </SUP><A HREF="#SONG-ETAL-1992">Song et al., 1992</A>; <A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>). We<SUP> </SUP>further reasoned that these<I> Msx1 </I>effectors would probably include<SUP> </SUP>cell cycle regulatory genes, particularly those that control<SUP> </SUP>exit from the cell cycle (the G<SUB>1</SUB>-G<SUB>0</SUB> transition), which generally<SUP> </SUP>precedes terminal differentiation (<A HREF="#SHERR-AND-ROBERTS-1999">Sherr and Roberts, 1999</A>;<SUP> </SUP><A HREF="#WALSH-AND-PERLMAN-1997">Walsh and Perlman, 1997</A>). Therefore, we asked whether misexpressing<I><SUP> </SUP>Msx1 </I>effected the steady-state expression levels of key cell<SUP> </SUP>cycle regulators, including G<SUB>1</SUB> cyclins (cyclin D1, cyclin D2,<SUP> </SUP>cyclin D3 and cyclin E), G<SUB>2</SUB> cyclins (cyclin A2 and cyclin B1),<SUP> </SUP>the<I> retinoblastoma </I>gene (<I>Rb1</I>), and the cyclin-dependent kinase<SUP> </SUP>inhibitors<I> p21WAF1/CIP </I>(<I>Cdkn1a </I>&#150; Mouse Genome Informatics),<I><SUP> </SUP>p27kip1 </I>(<I>Cdkn1b </I>&#150; Mouse Genome Informatics),<I> p57kip2 </I>(<I>Cdkn1c<SUP> </SUP></I>&#150; Mouse Genome Informatics) and<I> p16INK4a </I>(<I>Cdkn2a </I>&#150;<SUP> </SUP>Mouse Genome Informatics; <A HREF="#FIG2">Fig. 2</A>B). We examined the expression<SUP> </SUP>of these genes in C2C12 cells infected with a control retrovirus<SUP> </SUP>(Vector) or in cells infected with the<I> Msx1- </I>or<I> Msx1A</I>-expressing<SUP> </SUP>retroviruses.<SUP> </SUP><P>

Of the cell cycle regulatory genes examined, we found that the<SUP> </SUP>most prominent effect of <I>Msx1</I> misexpression was a robust increase<SUP> </SUP>in <I>cyclin D1</I> expression (20- to 30-fold), whereas misexpression<SUP> </SUP>of the <I>Msx1A</I> mutant had no significant effect (<A HREF="#FIG2">Fig. 2</A>B). In<SUP> </SUP>contrast, misexpression of <I>Msx1</I> modestly repressed <I>cyclin D3</I>,<SUP> </SUP><I>cyclin E</I>, <I>cyclin B1, Rb1</I> and <I>p21WAF1/CIP,</I> while it had little<SUP> </SUP>or no effect on <I>cyclin D2</I>, <I>cyclin A2, p27KIP1</I>, <I>p57KIP2</I> and <I>p16INK4a</I>.<SUP> </SUP>The finding that <I>Msx1</I> upregulates <I>cyclin D1</I> but not <I>cyclin E</I><SUP> </SUP>or the G<SUB>2</SUB> cyclins <I>(cyclin A2</I> and <I>cyclin B1),</I> is consistent with<SUP> </SUP>our observation that <I>Msx1</I> inhibits differentiation without promoting<SUP> </SUP>proliferation. Moreover, we have observed that a greater percentage<SUP> </SUP>of <I>Msx1-</I>expressing cells are found in the G<SUB>1</SUB> phase by flow cytometry<SUP> </SUP>(G. H. and C. A.-S., unpublished). A similar upregulation of<SUP> </SUP><I>cyclin D1</I> after misexpression of <I>Msx1</I> was observed in the adipocyte,<SUP> </SUP>chondrocyte and osteoblast lineages (data not shown).<SUP> </SUP><P>

<I>cyclin D1</I> misexpression has been shown to inhibit differentiation<SUP> </SUP>of myogenic cells in culture (<A HREF="#SKAPEK-ETAL-1995">Skapek et al., 1995</A>) and is therefore<SUP> </SUP>an excellent candidate for a primary downstream mediator of<SUP> </SUP><I>Msx1</I> activity. To assess whether the effect of misexpressing<SUP> </SUP><I>cyclin D1</I> is analogous to that of <I>Msx1</I>, we examined myogenic<SUP> </SUP>differentiation following misexpression of either gene in C2C12<SUP> </SUP>cells (<A HREF="#FIG3">Fig. 3</A>A). Similar to <I>Msx1</I>, misexpression of <I>cyclin D1</I><SUP> </SUP>resulted in marked inhibition of myogenic differentiation, apparent<SUP> </SUP>from the absence of myotube formation. Moreover, in addition<SUP> </SUP>to upregulating <I>cyclin D1</I> mRNA, <I>Msx1</I> upregulated cyclin D1 protein,<SUP> </SUP>which was inversely correlated with inhibition of MHC expression<SUP> </SUP>(<A HREF="#FIG3">Fig. 3</A>B). This result underscores the relationship between<SUP> </SUP>inhibition of differentiation by <I>Msx1</I> and upregulation of <I>cyclin<SUP> </SUP>D1</I>.<SUP> </SUP><P>

The cell cycle regulatory activities of cyclin D1 are mediated<SUP> </SUP>through its interaction with catalytic partners, particularly<SUP> </SUP>Cdk4 (<A HREF="#SHERR-AND-ROBERTS-1999">Sherr and Roberts, 1999</A>). Therefore, we asked whether<SUP> </SUP><I>Msx1</I> misexpression altered the protein level or activity of<SUP> </SUP>Cdk4. While <I>Msx1</I> misexpression did not alter the overall levels<SUP> </SUP>of total cellular Cdk4, the accumulation of Cdk4 in the nucleus<SUP> </SUP>was significantly increased relative to controls (<A HREF="#FIG3">Fig. 3</A>C).<SUP> </SUP>Co-immunoprecipitation analysis with anti-cyclin D1 antibody<SUP> </SUP>confirmed an increased association of Cdk4 with cyclin D1 in<SUP> </SUP><I>Msx1</I>-expressing cells (data not shown). Moreover, Cdk4 kinase<SUP> </SUP>activity was also substantially elevated in <I>Msx1</I>-expressing<SUP> </SUP>cells, including C2C12 cells and a human kidney cell line, 293T<SUP> </SUP>(<A HREF="#FIG3">Fig. 3</A>D). In contrast, misexpression of <I>Msx1</I> had no significant<SUP> </SUP>effect on the nuclear accumulation (<A HREF="#FIG3">Fig. 3</A>C) or kinase activity<SUP> </SUP>(<A HREF="#FIG3">Fig. 3</A>D) of Cdk2, the major partner of cyclin E. These findings<SUP> </SUP>are consistent with the observation that <I>Msx1</I> inhibits differentiation<SUP> </SUP>but does not promote cellular proliferation. Taken together,<SUP> </SUP>these data suggest that <I>Msx1</I> inhibits cellular differentiation<SUP> </SUP>through upregulation of <I>cyclin D1</I> and activation of Cdk4 activity.<SUP> </SUP><P>

<STRONG>Upregulation of <I>cyclin D1</I> is a conserved activity specific for the Msx family</STRONG><BR>

The <I>Msx2</I> homeobox gene has many similarities to <I>Msx1</I> with respect<SUP> </SUP>to its structure, expression pattern, biochemical properties,<SUP> </SUP>and biological functions (<A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>; <A HREF="#CATRON-ETAL-1996">Catron et al., 1996</A>;<SUP> </SUP><A HREF="#DAVIDSON-1995">Davidson, 1995</A>; <A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>). We have<SUP> </SUP>found that <I>Msx2</I> also inhibits differentiation of multiple mesenchymal<SUP> </SUP>lineages (<A HREF="#FIG4">Fig. 4</A>A and data not shown), and therefore we examined<SUP> </SUP>whether its misexpression also affected <I>cyclin D1</I> expression.<SUP> </SUP>Indeed, we found that misexpression of <I>Msx2</I> upregulated <I>cyclin<SUP> </SUP>D1</I> to a similar extent as <I>Msx1</I>, and was inversely correlated<SUP> </SUP>with inhibition of MHC expression and myotube formation (<A HREF="#FIG4">Figs 4</A>A,B,<SUP> </SUP><A HREF="#FIG5">5</A>B). In contrast, two members of the Dlx homeobox gene<SUP> </SUP>family (<I>Dlx2</I> and <I>Dlx5</I>), which are closely related to the Msx<SUP> </SUP>family (<A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>), inhibited differentiation<SUP> </SUP>but did not upregulate <I>cyclin D1</I> (<A HREF="#FIG4">Fig. 4</A>A,B). Furthermore, two<SUP> </SUP>members of the Hox gene family (<I>Hoxa7</I> and <I>Hoxc8</I>), which are<SUP> </SUP>less closely related to the Msx family did not inhibit differentiation<SUP> </SUP>or upregulate <I>cyclin D1</I> (<A HREF="#FIG4">Fig. 4</A>A,B). Therefore, we conclude<SUP> </SUP>that inhibition of differentiation through upregulation of <I>cyclin<SUP> </SUP>D1</I> is a conserved activity that is specific for the Msx family.<SUP> </SUP><P>

<A NAME="FIG4"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG4"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=104 HEIGHT=200 SRC="/content/vol128/issue12/images/small/DEV2657F4.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (84K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG4"
    onClick="startTarget('FIG4', 378, 640); this.href='/cgi/content-nw/full/128/12/2373/FIG4'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 4.</B> Upregulation of <I>cyclin D1</I> is a conserved activity of the Msx family. (A) C2C12 cells were infected with a control retrovirus (Vector) or retroviruses expressing the indicated homeoproteins and grown under conditions that promote differentiation. Scale bar: 0.1 mm. (B) Western blot analysis was performed using extracts prepared from C2C12 cells infected with a control retrovirus (Vector) or with retroviruses expressing the indicated homeoproteins, as in A. The panels show whole cell extracts probed with the indicated antibodies. Equivalent expression of the various homeoproteins is shown by <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Myc, which detects the Myc epitope present at the N-terminal region of each homeoprotein. RNA polymerase II (<IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-RNA PolII) is a control for protein loading.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="FIG5"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG5"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=141 SRC="/content/vol128/issue12/images/small/DEV2657F5.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (66K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG5">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG5"
    onClick="startTarget('FIG5', 590, 511); this.href='/cgi/content-nw/full/128/12/2373/FIG5'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG5">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 5.</B> Regions of Msx1 required for upregulation of <I>cyclin D1</I> include its transcriptional domains. (A) Schematic diagrams showing the primary structures of Msx1 and Msx2; the percent identity in the N-terminal region, homeodomain and C-terminal regions are indicated. Also shown are the protein regions contained in the truncated Msx1 derivatives, Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1, Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">2 and Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">3. (B) Western blot analyses were performed using extracts prepared from differentiated C2C12 cells following infection with a control retrovirus (Vector) or with retroviruses expressing the indicated Msx protein. Western blots were probed with <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-cyclin D1 or <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-MHC antibodies; <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-RNA PolII is a control for protein loading. (C) C2C12 cells were infected with a control retrovirus (Vector) or a retrovirus expressing an Msx1-estrogen receptor fusion protein (Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1-ER). Infected cells were incubated in the presence (+) or absence (-) of tamoxifen (100 nM) and grown under conditions that promote differentiation. Scale bar: 0.1 mm. (D) Ribonuclease protection analyses were performed using total RNA prepared from C2C12 cells that had been infected with a control retrovirus (Vector) or with a retrovirus expressing Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1-ER. Infected cells were treated with tamoxifen (100 nM) for the indicated times and ribonuclease protection assays were performed using a <I>cyclin D1</I> riboprobe or an <I>RPL32</I> riboprobe as a control for RNA loading.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG>The transcriptional domains of Msx1 are required for upregulation of <I>cyclin D1</I></STRONG><BR>

To gain further insights into the mechanism(s) by which <I>Msx1</I><SUP> </SUP>inhibits differentiation and upregulates <I>cyclin D1</I>, we used<SUP> </SUP>an inducible expression system that is regulated by the hormone<SUP> </SUP>binding domain of the estrogen receptor. First, we mapped the<SUP> </SUP>region(s) of Msx1 required for inhibition of differentiation<SUP> </SUP>and upregulation of <I>cyclin D1</I> by generating a series of truncated<SUP> </SUP>derivatives that each contain the homeodomain, but lack varying<SUP> </SUP>portions of the N or C terminus (Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1, Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">2 or Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">3) (<A HREF="#FIG5">Fig. 5</A>A).<SUP> </SUP>We introduced these derivatives into C2C12 cells by retroviral<SUP> </SUP>gene transfer and examined their effects on myogenic differentiation.<SUP> </SUP>This analysis revealed that a truncated Msx1 protein containing<SUP> </SUP>the N-terminal domain plus the homeodomain (Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1) upregulated<SUP> </SUP>cyclin D1, while it inhibited MHC expression and myotube formation<SUP> </SUP>(<A HREF="#FIG5">Fig. 5</A>B, data not shown). In contrast, a truncated Msx1 protein<SUP> </SUP>containing the homeodomain but lacking N-terminal or C-terminal<SUP> </SUP>sequences (Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">2) or a protein containing the homeodomain plus<SUP> </SUP>C-terminal sequences (Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">3) had no such effect (<A HREF="#FIG5">Fig. 5</A>B).<SUP> </SUP><P>

Next, we generated a chimeric fusion protein in which the essential<SUP> </SUP>regions of Msx1, namely the N-terminal region and the homeodomain,<SUP> </SUP>were fused with the hormone-binding domain of a tamoxifen-responsive<SUP> </SUP>mutant of the estrogen receptor (<A HREF="#LITTLEWOOD-ETAL-1995">Littlewood et al., 1995</A>). Infection<SUP> </SUP>of C2C12 cells with a retrovirus expressing this <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1-ER</I> chimeric<SUP> </SUP>gene resulted in tamoxifen-dependent inhibition of differentiation<SUP> </SUP>(<A HREF="#FIG5">Fig. 5</A>C) that was comparable with that of native <I>Msx1</I> (see<SUP> </SUP><A HREF="#FIG1">Fig. 1</A>A). We used this estrogen receptor-regulated expression<SUP> </SUP>system to evaluate the time course for activation of <I>cyclin<SUP> </SUP>D1</I> by <I>Msx1</I>. In <I>Msx1<IMG SRC="/math/Dgr.gif" ALT="{Delta}" BORDER="0">1-ER</I>-infected cells, <I>cyclin D1</I> expression<SUP> </SUP>increased as early as 2 hours after addition of tamoxifen and<SUP> </SUP>peaked by 24 hours (<A HREF="#FIG5">Fig. 5</A>D), suggesting that <I>cyclin D1</I> represents<SUP> </SUP>an early response gene for <I>Msx1</I>. However, we were unable to<SUP> </SUP>address whether <I>cyclin D1</I> is a direct target of <I>Msx1</I> using cycloheximide<SUP> </SUP>treatment, as addition of cycloheximide by itself increased<SUP> </SUP><I>cyclin D1</I> mRNA levels (data not shown).<SUP> </SUP><P>

The ability for <I>Msx1</I> to inhibit differentiation and upregulate<SUP> </SUP>cyclin D1 primarily requires the N-terminal domain (<A HREF="#FIG5">Fig. 5</A>A,B);<SUP> </SUP>notably, this region contains the major regulatory domains defined<SUP> </SUP>in transcription assays (<A HREF="#CATRON-ETAL-1996">Catron et al., 1996</A>; <A HREF="#CATRON-ETAL-1995">Catron et al., 1995</A>).<SUP> </SUP>However, as Msx proteins are potent transcriptional repressors<SUP> </SUP>and have no reported activator potential (<A HREF="#CATRON-ETAL-1995">Catron et al., 1995</A>),<SUP> </SUP>it is likely that <I>Msx1</I> upregulates <I>cyclin D1</I> indirectly rather<SUP> </SUP>than by direct activation through <I>cyclin D1</I> promoter elements.<SUP> </SUP>Indeed, we have found that <I>Msx1</I> does not activate the <I>cyclin<SUP> </SUP>D1</I> promoter in transient transfection assays, irrespective of<SUP> </SUP>the cell type or the human or rat <I>cyclin D1</I> promoter/enhancer<SUP> </SUP>regions examined (G. H. and C. A.-S., unpublished).<SUP> </SUP><P>

<STRONG><I>Msx1</I> inhibits mammary epithelial differentiation and upregulates <I>cyclin D1</I> in transgenic mice</STRONG><BR>

To extend our findings, we developed a transgenic mouse system<SUP> </SUP>to examine the consequences of <I>Msx1</I> misexpression for differentiation<SUP> </SUP>and <I>cyclin</I> D1 expression in vivo. We chose to investigate the<SUP> </SUP>mammary gland because of the known expression and functional<SUP> </SUP>significance of Msx and <I>cyclin D1</I> genes in this tissue. In particular,<SUP> </SUP>both <I>Msx1</I> and <I>Msx2</I> are expressed in the mammary epithelium during<SUP> </SUP>embryogenesis and pregnancy, and loss of Msx gene function results<SUP> </SUP>in profound defects in mammary gland morphogenesis during development<SUP> </SUP>(<A HREF="#FRIEDMANN-AND-DANIEL-1996">Friedmann and Daniel, 1996</A>; <A HREF="#PHIPPARD-ETAL-1996">Phippard et al., 1996</A>; <A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>).<SUP> </SUP>Moreover, <I>cyclin D1</I> is essential for mammary<SUP> </SUP>gland differentiation and function during pregnancy (<A HREF="#FANTL-ETAL-1999">Fantl et al., 1999</A>;<SUP> </SUP><A HREF="#FANTL-ETAL-1995">Fantl et al., 1995</A>; <A HREF="#SICINSKI-ETAL-1995">Sicinski et al., 1995</A>).<SUP> </SUP><P>

Initially, we asked whether <I>Msx1</I> also inhibited differentiation<SUP> </SUP>of mammary epithelial cells in culture, analogous to its effects<SUP> </SUP>on mesenchymal cell types (<A HREF="#FIG6">Fig. 6</A>A). For this purpose, we used<SUP> </SUP>HC11 cells, which undergo terminal differentiation and produce<SUP> </SUP>milk proteins, including &#223;-casein, after treatment<SUP> </SUP>with lactogenic hormones (<A HREF="#HYNES-ETAL-1990">Hynes et al., 1990</A>). We found that<SUP> </SUP>differentiation of HC11 cells was inhibited by misexpression<SUP> </SUP>of <I>Msx1</I>, but not by <I>Msx1A</I>, as determined by the nearly complete<SUP> </SUP>absence of <I>&#223;-casein</I> (<I>Csnb</I> &#150; Mouse Genome Informatics)<SUP> </SUP>expression, and that this inhibition correlated with upregulation<SUP> </SUP>of <I>cyclin D1</I> expression (<A HREF="#FIG6">Fig. 6</A>A).<SUP> </SUP><P>

<A NAME="FIG6"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG6"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=77 SRC="/content/vol128/issue12/images/small/DEV2657F6.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (43K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG6">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG6"
    onClick="startTarget('FIG6', 590, 370); this.href='/cgi/content-nw/full/128/12/2373/FIG6'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG6">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 6.</B> <I>Msx1</I> inhibits mammary epithelial differentiation and upregulates <I>cyclin D1</I> in cell culture and in vivo. (A) Ribonuclease protection analyses were performed using total RNA obtained from HC11 mammary epithelial cells infected with a control retrovirus (Vector) or with those expressing <I>Msx1</I> or <I>Msx1A</I>. Infected cells were grown under normal growth conditions (undifferentiated) or in conditions that promote differentiation (differentiated). (B) Ribonuclease protection analyses of total RNA prepared from the mammary fat pads of wild type (WT) and transgenic (TG) mice from virgin or pregnant females at the indicated stages. (A,B) Ribonuclease protection assays were performed using the indicated riboprobes; each lane contains 10 &#181;g of total RNA, except for <I>&#223;-casein</I> in which 1.5 &#181;g of RNA was used. <I>RPL32</I> is a control for RNA loading.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


Next, we generated transgenic mice in which the MMTV LTR was<SUP> </SUP>used to direct <I>Msx1</I> transgene expression to the mammary epithelium<SUP> </SUP>(<A HREF="#STEWART-ETAL-1984">Stewart et al., 1984</A>). In virgin female mice, the mammary gland<SUP> </SUP>consists of a simple branched ductal epithelium that is embedded<SUP> </SUP>in a stromal fat pad. No significant phenotypic differences<SUP> </SUP>were observed in MMTV-<I>Msx1</I> transgenic virgin females relative<SUP> </SUP>to wild type (<I>n</I>=6; <A HREF="#FIG7">Fig. 7</A>A). In contrast, we observed significant<SUP> </SUP>differences during pregnancy, when the epithelial ducts normally<SUP> </SUP>undergo extensive branching and differentiation to form complex<SUP> </SUP>lobuloalveolar structures that produce milk during lactation.<SUP> </SUP>In two independent transgenic lines that express <I>Msx1</I> at high<SUP> </SUP>levels (see below), we observed a significant inhibition of<SUP> </SUP>lobuloalveolar development with relatively normal side branching<SUP> </SUP>during pregnancy (<I>n</I>=18; <A HREF="#FIG7">Fig. 7</A>A). This defect was most apparent<SUP> </SUP>during the proliferative phase of lobuloalveolar development<SUP> </SUP>from 9.5 to 14.5 days post coitum (dpc), corresponding to the<SUP> </SUP>stages when endogenous Msx expression is downregulated in wild-type<SUP> </SUP>mice (<A HREF="#FRIEDMANN-AND-DANIEL-1996">Friedmann and Daniel, 1996</A>; <A HREF="#PHIPPARD-ETAL-1996">Phippard et al., 1996</A>). During<SUP> </SUP>lactation, the lobuloalveolar structures of MMTV-<I>Msx1</I> transgenic<SUP> </SUP>mammary glands appeared less complex than those of their wild-type<SUP> </SUP>littermates (<I>n</I>=4; <A HREF="#FIG7">Fig. 7</A>A). These phenotypic changes appear<SUP> </SUP>to correspond to delayed maturation of the mammary epithelium;<SUP> </SUP>however, the transgenic females were able to lactate and nurse<SUP> </SUP>their progeny, and after weaning would undergo normal mammary<SUP> </SUP>gland involution (data not shown).<SUP> </SUP><P>

<A NAME="FIG7"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG7"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=109 SRC="/content/vol128/issue12/images/small/DEV2657F7.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (61K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG7">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG7"
    onClick="startTarget('FIG7', 590, 440); this.href='/cgi/content-nw/full/128/12/2373/FIG7'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG7">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 7.</B> Impaired mammary epithelial differentiation and increased <I>cyclin D1</I> expression in MMTV-<I>Msx1</I> transgenic mice. (A) Whole-mount Hematoxylin staining of mammary fat pads from female virgin, pregnant (14.5 dpc), or lactating MMTV-<I>Msx1</I> transgenic mice and wild-type littermate controls, shown in low-power and high-power views. Although terminal end bud formation appears normal in the virgin transgenic and wild-type mice (arrows), retarded lobuloalveolar formation is observed in pregnant transgenics at 14.5 dpc (arrows). At this stage, and in lactating mice, there is reduced complexity of lobuloalveolar structures (arrows). (B) Immunohistochemical detection of cyclin D1 and Msx1 protein in sections from mammary glands of wild type and MMTV-<I>Msx1</I> transgenic pregnant mice at 14.5 dpc. Note the elevated expression of Msx1 and cyclin D1 in nuclei of lumenal epithelial cells (arrows) in the mammary glands of the transgenic mice compared with their wild-type littermate controls. Scale bars: 0.5 mm in A; 0.05 mm in B.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


Notably, the phenotypic defects in mammary gland differentiation<SUP> </SUP>in <I>Msx1</I> transgenic mice were paralleled by increased levels<SUP> </SUP>of <I>cyclin D1</I> and were inversely correlated with reduced <I>&#223;-casein</I><SUP> </SUP>expression (<A HREF="#FIG6">Figs 6</A>B, <A HREF="#FIG7">7</A>B). By immunohistochemical staining, cyclin<SUP> </SUP>D1 protein was detected at high levels in nuclei of the transgenic<SUP> </SUP>mammary epithelium, correlating with the elevated levels of<SUP> </SUP>nuclear Msx1 protein (<I>n</I>=5; <A HREF="#FIG7">Fig. 7</A>B). Furthermore, increased<SUP> </SUP>expression of <I>cyclin D1</I> mRNA was found in transgenic mammary<SUP> </SUP>glands during mid- to late-pregnancy (<IMG SRC="/math/sim.gif" ALT="~" BORDER="0">fivefold at 14.5 dpc;<SUP> </SUP><I>n</I>=6), consistent with their observed morphological defects (compare<SUP> </SUP><A HREF="#FIG6">Fig. 6</A>B with 7A). Interestingly, this upregulation of <I>cyclin<SUP> </SUP>D1</I> in the <I>Msx1</I> transgenic mice occurred during stages in which<SUP> </SUP><I>cyclin D1</I> is normally expressed in wild-type mice, whereas <I>cyclin<SUP> </SUP>D1</I> is downregulated during lactation and involution in both<SUP> </SUP>wild-type and transgenic mice, despite the persistence of <I>Msx1</I><SUP> </SUP>transgene expression during these stages. In summary, these<SUP> </SUP>findings support the biological significance of <I>Msx1</I> as an inhibitor<SUP> </SUP>of differentiation through its ability to upregulate <I>cyclin<SUP> </SUP>D1</I> in the mammary gland.<SUP> </SUP><P>

<A NAME="SEC4"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
DISCUSSION
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">INTRODUCTION<BR></A>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">MATERIALS AND METHODS<BR></A>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>DISCUSSION</FONT><BR>
<A HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

We have investigated the molecular mechanisms by which Msx homeobox<SUP> </SUP>genes control cellular processes of differentiation and proliferation<SUP> </SUP>during development. We have found that Msx genes function as<SUP> </SUP>general inhibitors of differentiation of mesenchymal and epithelial<SUP> </SUP>progenitor cells in culture and in vivo, and that this inhibition<SUP> </SUP>is correlated with upregulation of <I>cyclin D1</I> and Cdk4 activity.<SUP> </SUP>We propose that a primary function of Msx genes is to maintain<SUP> </SUP><I>cyclin D1</I> expression in progenitor populations during development,<SUP> </SUP>thereby preventing these cells from exiting the cell cycle and<SUP> </SUP>undergoing terminal differentiation (<A HREF="#FIG8">Fig. 8</A>). Our findings establish<SUP> </SUP>a link between homeobox gene action and cell cycle control,<SUP> </SUP>and implicate <I>Msx1</I> as a physiological mediator of <I>cyclin D1</I><SUP> </SUP>expression in vivo, which is of particular significance given<SUP> </SUP>the role of <I>cyclin D1</I> in mammary differentiation and carcinogenesis.<SUP> </SUP><P>

<A NAME="FIG8"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/128/12/2373/FIG8"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=170 SRC="/content/vol128/issue12/images/small/DEV2657F8.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (13K):<BR>
<NOBR><A HREF="/cgi/content/full/128/12/2373/FIG8">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/128/12/2373/FIG8"
    onClick="startTarget('FIG8', 590, 573); this.href='/cgi/content-nw/full/128/12/2373/FIG8'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="FIG8">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Fig. 8</B> A model for Msx function in cell cycle regulation. <I>Msx1</I> indirectly upregulates <I>cyclin D1</I> expression (red arrows), resulting in block of cell cycle exit (red bar) and subsequent differentiation. Although <I>cyclin D1</I> can promote cellular proliferation (green arrow), <I>Msx1</I> does not, presumably through its effects on other cell cycle components (broken red arrow). Thus, overexpression of <I>Msx1</I> would block cell cycle exit without promoting proliferation, while loss of <I>Msx1</I> activity might lead to premature cell cycle exit.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG>Homeobox genes as regulators of cell differentiation and proliferation</STRONG><BR>

The expression patterns of Msx genes are consistent with a role<SUP> </SUP>for members of this gene family to function as general inhibitors<SUP> </SUP>of differentiation. Thus, expression of Msx genes at all stages<SUP> </SUP>of embryogenesis and adulthood is associated with multipotent<SUP> </SUP>progenitor cells, while Msx expression has not been found in<SUP> </SUP>any terminally differentiated cell types (<A HREF="#BENDALL-AND-ABATE-SHEN-2000">Bendall and Abate-Shen, 2000</A>;<SUP> </SUP><A HREF="#DAVIDSON-1995">Davidson, 1995</A>). For example, during early embryogenesis,<SUP> </SUP>Msx genes are broadly expressed in mesoderm progenitors emerging<SUP> </SUP>from the primitive streak. Later in embryogenesis, Msx gene<SUP> </SUP>expression is associated with progenitors that are restricted<SUP> </SUP>to particular lineages, such as the proliferating cells in the<SUP> </SUP>limb bud that give rise to its skeletal elements. Furthermore,<SUP> </SUP>in adults Msx expression is limited to the stem cells of tissues<SUP> </SUP>capable of undergoing self renewal, such as the mammary epithelium,<SUP> </SUP>uterine epithelium and basal epithelium of the dermis (<A HREF="#FRIEDMANN-AND-DANIEL-1996">Friedmann and Daniel, 1996</A>;<SUP> </SUP><A HREF="#NOVEEN-ETAL-1995">Noveen et al., 1995</A>; <A HREF="#PAVLOVA-ETAL-1994">Pavlova et al., 1994</A>;<SUP> </SUP><A HREF="#PHIPPARD-ETAL-1996">Phippard et al., 1996</A>). Interestingly, Msx gene expression is<SUP> </SUP>also found in various carcinoma cell lines and tumors (<A HREF="#SUZUKI-ETAL-1993">Suzuki et al., 1993</A>)<SUP> </SUP>(K. Catron and C. A.-S., unpublished), and forced<SUP> </SUP>expression of <I>Msx1</I> promotes cellular transformation (<A HREF="#SONG-ETAL-1992">Song et al., 1992</A>),<SUP> </SUP>raising the possibility that Msx expression contributes<SUP> </SUP>to the reversion of differentiation that is characteristic of<SUP> </SUP>carcinoma cells. Notably, a recent study has shown that <I>Msx1</I><SUP> </SUP>overexpression can lead to de-differentiation of C2C12 cells<SUP> </SUP>into a mesenchymal progenitor that is capable of differentiating<SUP> </SUP>into multiple cell lineages (<A HREF="#ODELBERG-ETAL-2000">Odelberg et al., 2000</A>). If this<SUP> </SUP>observation is confirmed in other cell types, this finding combined<SUP> </SUP>with the present study implies that <I>trans</I>-differentiation induced<SUP> </SUP>by <I>Msx1</I> may be mediated by modulation of cell cycle regulators.<SUP> </SUP><P>

In addition to the Msx gene family, numerous other homeobox<SUP> </SUP>genes have been implicated in controlling aspects of cellular<SUP> </SUP>proliferation and differentiation during embryogenesis, while<SUP> </SUP>their aberrant expression is associated with cellular transformation.<SUP> </SUP>The most well studied in this regard are the Hox genes, which<SUP> </SUP>are the largest family of homeobox genes (<A HREF="#KRUMLAUF-1994">Krumlauf, 1994</A>). Although<SUP> </SUP>loss-of-function mutation of members of the Hox family produces<SUP> </SUP>distinct phenotypic outcomes, certain common themes also emerge.<SUP> </SUP>Notably, Hox mutants often display vertebral transformations<SUP> </SUP>that have been interpreted as changes in rates of cell proliferation<SUP> </SUP>and/or survival (<A HREF="#DUBOULE-1995">Duboule, 1995</A>). Hox genes, as well as their<SUP> </SUP>essential co-factors, the Pbx genes, are aberrantly expressed<SUP> </SUP>in leukemias and many solid tumors, and their forced expression<SUP> </SUP>is associated with cellular transformation (<A HREF="#CILLO-ETAL-1999">Cillo et al., 1999</A>;<SUP> </SUP><A HREF="#MAULBECKER-AND-GRUSS-1993">Maulbecker and Gruss, 1993</A>). Furthermore, the Gax homeobox gene<SUP> </SUP>negatively regulates cardiomyocyte proliferation through upregulation<SUP> </SUP>of the cell cycle regulatory gene, <I>p21WAF1/CIP</I> (<A HREF="#SMITH-ETAL-1997">Smith et al., 1997</A>).<SUP> </SUP>Thus, the link between homeobox gene function and regulation<SUP> </SUP>of the cell cycle machinery is likely to emerge as a prevalent<SUP> </SUP>theme.<SUP> </SUP><P>

<STRONG><I>cyclin D1</I> is a downstream effector of Msx gene function</STRONG><BR>

<I>cyclin D1</I> inhibits differentiation of multiple lineages through<SUP> </SUP>its ability to block exit from the cell cycle, and thus represents<SUP> </SUP>an excellent candidate downstream effector for <I>Msx1</I> in culture<SUP> </SUP>(<A HREF="#SHERR-AND-ROBERTS-1999">Sherr and Roberts, 1999</A>; <A HREF="#WALSH-AND-PERLMAN-1997">Walsh and Perlman, 1997</A>). Indeed,<SUP> </SUP><I>cyclin D1</I> blocks <I>MyoD</I> activity in myogenic progenitors (<A HREF="#RAO-AND-KOHTZ-1995">Rao and Kohtz, 1995</A>;<SUP> </SUP><A HREF="#SKAPEK-ETAL-1995">Skapek et al., 1995</A>), which is noteworthy as<SUP> </SUP><I>Msx1</I> inhibits <I>MyoD</I> expression in cell culture as well as in<SUP> </SUP>vivo (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>). However,<SUP> </SUP>the consequences of <I>Msx1</I> misexpression are not entirely analogous<SUP> </SUP>to those of <I>cyclin D1</I>, as <I>Msx1</I> does not significantly promote<SUP> </SUP>cellular proliferation, resulting in a greater percentage of<SUP> </SUP><I>Msx1</I>-expressing cells in the G<SUB>1</SUB> phase. This distinction probably<SUP> </SUP>reflects the fact that <I>Msx1</I> upregulates <I>cyclin D1</I> but not <I>cyclin<SUP> </SUP>E</I> or the G<SUB>2</SUB> cyclins.<SUP> </SUP><P>

In addition, <I>cyclin D1</I> is an excellent candidate downstream<SUP> </SUP>effector of Msx in vivo. Indeed, we have demonstrated that overexpression<SUP> </SUP>of <I>Msx1</I> in the mammary gland results in upregulation of <I>cyclin<SUP> </SUP>D1</I> expression. Furthermore, the expression patterns of <I>Msx1</I><SUP> </SUP>and <I>Msx2</I> overlap with that of <I>cyclin D1</I> at early stages of embryogenesis<SUP> </SUP>in the primitive streak and lateral mesoderm and later in the<SUP> </SUP>limb mesenchyme, neural tube, craniofacial mesenchyme, retina<SUP> </SUP>and mammary gland (<A HREF="#WIANNY-ETAL-1998">Wianny et al., 1998</A>; G. H. and C. A.-S.,<SUP> </SUP>unpublished). Moreover, the phenotypes of <I>Msx1</I>, <I>Msx2</I> and <I>cyclin<SUP> </SUP>D1</I> loss-of-function mutations share similarities, but are not<SUP> </SUP>identical, as discussed below. Our current findings do not preclude<SUP> </SUP>negative regulation by Msx genes of lineage-specific genes such<SUP> </SUP>as <I>MyoD</I> or <I>osteocalcin</I>, which are involved in terminal differentiation<SUP> </SUP>(<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>; <A HREF="#NEWBERRY-ETAL-1997">Newberry et al., 1997</A>; <A HREF="#WOLOSHIN-ETAL-1995">Woloshin et al., 1995</A>),<SUP> </SUP>but instead expand the repertoire of their downstream<SUP> </SUP>effectors to include global cell cycle regulators.<SUP> </SUP><P>

Although we have found that <I>cyclin D1</I> is activated as an early<SUP> </SUP>response gene of <I>Msx1</I>, the available evidence suggests that<SUP> </SUP>it is likely to be an indirect target. Indeed, Msx genes encode<SUP> </SUP>transcriptional repressors and have not been previously implicated<SUP> </SUP>as transcriptional activators (<A HREF="#CATRON-ETAL-1996">Catron et al., 1996</A>; <A HREF="#CATRON-ETAL-1995">Catron et al., 1995</A>).<SUP> </SUP>Given the known significance of protein-protein<SUP> </SUP>interactions for mediating Msx function (<A HREF="#BENDALL-ETAL-1999">Bendall et al., 1999</A>;<SUP> </SUP><A HREF="#ZHANG-ETAL-1997">Zhang et al., 1997</A>), it seems plausible that <I>Msx1</I> activates<SUP> </SUP><I>cyclin D1</I> through interaction with other transcriptional regulators,<SUP> </SUP>perhaps those directly upstream of <I>cyclin D1</I>.<SUP> </SUP><P>

<STRONG>A model for Msx gene function</STRONG><BR>

Based on our findings, we propose a model for the mechanism<SUP> </SUP>of Msx gene function in cellular proliferation and differentiation<SUP> </SUP>(<A HREF="#FIG8">Fig. 8</A>). We find that Msx genes maintain cells in a proliferative<SUP> </SUP>state by blocking exit from the cell cycle, while not actively<SUP> </SUP>promoting proliferation. Moreover, this model explains the apparent<SUP> </SUP>activity of Msx genes in inhibiting cellular differentiation<SUP> </SUP>as a consequence of preventing cell cycle exit. Thus, the model<SUP> </SUP>distinguishes between a direct effect on the cell cycle and<SUP> </SUP>an indirect effect on differentiation.<SUP> </SUP><P>

Our model provides a basis for reconciling the observed similarities<SUP> </SUP>between the phenotypes of Msx loss-of-function and gain-of-function<SUP> </SUP>mutations (<A HREF="#JABS-ETAL-1993">Jabs et al., 1993</A>; <A HREF="#LIU-ETAL-1995">Liu et al., 1995</A>; <A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>;<SUP> </SUP><A HREF="#SATOKATA-AND-MAAS-1994">Satokata and Maas, 1994</A>; <A HREF="#WILKIE-ETAL-2000">Wilkie et al., 2000</A>; <A HREF="#WINOGRAD-ETAL-1997">Winograd et al., 1997</A>).<SUP> </SUP>For example, mutant mice lacking either <I>Msx2</I><SUP> </SUP>or both <I>Msx1</I> and <I>Msx2</I> display profound defects in mammary gland<SUP> </SUP>development that have been interpreted as arrested differentiation<SUP> </SUP>(<A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>). In the context of our model, loss of<SUP> </SUP>Msx function is predicted to result in premature exit of progenitor<SUP> </SUP>cells from the cell cycle, resulting in decreased proliferation<SUP> </SUP>and consequently impaired morphogenesis. Conversely, in <I>MMTV-Msx1</I><SUP> </SUP>transgenic mice, which also display defects in mammary gland<SUP> </SUP>differentiation, overexpression of Msx genes is predicted to<SUP> </SUP>block progenitor cells from exiting the cell cycle; in the absence<SUP> </SUP>of increased proliferation, the outcome would also be impaired<SUP> </SUP>morphogenesis. Comparable arguments can be made for the similar<SUP> </SUP>phenotypes found in loss- and gain-of-function analyses of Msx<SUP> </SUP>function in cranial development (<A HREF="#JABS-ETAL-1993">Jabs et al., 1993</A>; <A HREF="#LIU-ETAL-1995">Liu et al., 1995</A>;<SUP> </SUP><A HREF="#SATOKATA-ETAL-2000">Satokata et al., 2000</A>; <A HREF="#SATOKATA-AND-MAAS-1994">Satokata and Maas, 1994</A>; <A HREF="#WILKIE-ETAL-2000">Wilkie et al., 2000</A>;<SUP> </SUP><A HREF="#WINOGRAD-ETAL-1997">Winograd et al., 1997</A>). In addition, similar phenotypes<SUP> </SUP>following both loss- and gain-of-function mutations have been<SUP> </SUP>reported for other homeobox genes (e.g. <A HREF="#POLLOCK-ETAL-1992">Pollock et al., 1992</A>).<SUP> </SUP><P>

<I>cyclin D1</I> loss-of-function mutant mice display delayed maturation<SUP> </SUP>of the mammary gland that has been interpreted as partial blockage<SUP> </SUP>of differentiation (<A HREF="#FANTL-ETAL-1999">Fantl et al., 1999</A>; <A HREF="#FANTL-ETAL-1995">Fantl et al., 1995</A>;<SUP> </SUP><A HREF="#SICINSKI-ETAL-1995">Sicinski et al., 1995</A>). In particular, these mice undergo normal<SUP> </SUP>early proliferation and side-branching, but greatly reduced<SUP> </SUP>lobuloalveolar formation (<A HREF="#FANTL-ETAL-1999">Fantl et al., 1999</A>), resembling the<SUP> </SUP>phenotype of MMTV-<I>Msx1</I> transgenic mice. In <I>cyclin D1</I> loss-of-function<SUP> </SUP>mutants, progenitor cells would be predicted to exit the cell<SUP> </SUP>cycle prematurely, resulting in less proliferation and hence<SUP> </SUP>impaired morphogenesis; counterintuitively, the outcome would<SUP> </SUP>thus be similar to that of MMTV-<I>Msx1</I> transgenic mice. Conversely,<SUP> </SUP><I>MMTV-cyclin D1</I> transgenic mice display mammary epithelial hyperproliferation<SUP> </SUP>that ultimately leads to carcinoma (<A HREF="#WANG-ETAL-1994">Wang et al., 1994</A>), consistent<SUP> </SUP>with the well-known activity of <I>cyclin D1</I> in promoting cellular<SUP> </SUP>proliferation, unlike <I>Msx1</I>.<SUP> </SUP><P>

The potential for Msx genes to upregulate <I>cyclin D1</I> has important<SUP> </SUP>implications for mammary carcinogenesis. Upregulation of cyclin<SUP> </SUP>D1 protein expression is one of the most prevalent alterations<SUP> </SUP>in breast carcinoma, occurring in approximately 40% of cases<SUP> </SUP>(<A HREF="#HALL-AND-PETERS-1996">Hall and Peters, 1996</A>). However, <I>cyclin D1</I> gene amplification<SUP> </SUP>occurs in only a fraction of these cases, indicating that other<SUP> </SUP>factors are responsible for upregulating <I>cyclin D1</I>. Thus, our<SUP> </SUP>findings suggest that a potential role for Msx genes in breast<SUP> </SUP>carcinogenesis deserves further study.<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>


<A NAME="ACK"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
ACKNOWLEDGMENTS
</FONT></TH></TR></TABLE>
&nbsp;<BR>

We acknowledge the expert technical assistance of Nishita Desai<SUP> </SUP>for immunohistochemistry. We thank Dr Emma Lees for much valuable<SUP> </SUP>input and Drs Lee, Fang Liu and Isao Matsuura for advice on<SUP> </SUP>Cdk kinase assays. We acknowledge Dr Danny Reinberg for RNA<SUP> </SUP>PolII antisera, Dr Charles J. Sherr for the murine cyclin D1,<SUP> </SUP>cyclin D2, cyclin D3, cyclin E and p16/ink4a cDNAs, Dr Ed Harlow<SUP> </SUP>for the murine retinoblastoma cDNA, Dr Bert Vogelstein for the<SUP> </SUP>murine p21WAF1/CIP1 cDNA, Dr Joan Massague for the murine p27kip<SUP> </SUP>and p57kip2 cDNAs, and Dr Edward B Ziff for the <I>cyclin D1</I> promoter<SUP> </SUP>plasmids. We thank Dr Andrew Bendall and members of the Abate-Shen<SUP> </SUP>laboratory for stimulating discussion and advice throughout<SUP> </SUP>the course of this work. We also thank Drs Tom Curran, Celine<SUP> </SUP>Gelinas, Emma Lees, Fang Liu, Arnold Rabson and Nancy Walworth<SUP> </SUP>for comments on the manuscript. This work is supported by NIH<SUP> </SUP>grants to C. A.-S. (HD29446) and to M. M. S. (HL60212 and HD38766),<SUP> </SUP>and a pre-doctoral fellowship from the American Heart Association<SUP> </SUP>(NJ97SA04) to G. H.<SUP> </SUP><P>




<A NAME="BIBL"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
REFERENCES
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">INTRODUCTION<BR></A>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">MATERIALS AND METHODS<BR></A>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS<BR></A>
<A HREF="#SEC4"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">DISCUSSION<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>REFERENCES</FONT><BR>
</FONT></TH></TR></TABLE>
&nbsp;<BR>


<A NAME="AHRENS-ETAL-1977"><!-- null --></A>
<P><B>Ahrens, P. B., Solursh, M. and Reiter, R. S.</B> (1977). Stage-related capacity for limb chondrogenesis in cell culture. <I>Dev. Biol.</I> <B>60</B>, 69-82.<!-- HIGHWIRE ID="128:12:2373:1" --><A HREF="/cgi/external_ref?access_num=198274&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="BENDALL-AND-ABATE-SHEN-2000"><!-- null --></A>
<P><B>Bendall, A. J. and Abate-Shen, C.</B> (2000). Roles for Msx and Dlx homeoproteins in vertebrate development. <I>Gene</I> <B>247</B>, 17-31.<!-- HIGHWIRE ID="128:12:2373:2" --><A HREF="/cgi/external_ref?access_num=10773441&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="BENDALL-ETAL-1999"><!-- null --></A>
<P><B>Bendall, A. J., Ding, J., Hu, G., Shen, M. M. and Abate-Shen, C.</B> (1999). Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors. <I>Development</I> <B>126</B>, 4965-4976.<!-- HIGHWIRE ID="128:12:2373:3" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=develop&resid=126/22/4965" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="CATRON-ETAL-1995"><!-- null --></A>
<P><B>Catron, K. M., Zhang, H., Marshall, S. C., Inostroza, J. A., Wilson, J. M. and Abate, C.</B> (1995). Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. <I>Mol. Cell. Biol.</I> <B>15</B>, 861-871.<!-- HIGHWIRE ID="128:12:2373:4" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=15/2/861" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="CATRON-ETAL-1996"><!-- null --></A>
<P><B>Catron, K. M., Wang, H., Hu, G., Shen, M. M. and Abate-Shen, C.</B> (1996). Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy. <I>Mech. Dev.</I> <B>55</B>, 185-199.<!-- HIGHWIRE ID="128:12:2373:5" --><A HREF="/cgi/external_ref?access_num=8861098&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="CILLO-ETAL-1999"><!-- null --></A>
<P><B>Cillo, C., Faiella, A., Cantile, M. and Boncinelli, E.</B> (1999). Homeobox genes and cancer. <I>Exp. Cell Res.</I> <B>248</B>, 1-9.<!-- HIGHWIRE ID="128:12:2373:6" --><A HREF="/cgi/external_ref?access_num=10094807&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="DAVIDSON-1995"><!-- null --></A>
<P><B>Davidson, D.</B> (1995). The function and evolution of Msx genes: pointers and paradoxes. <I>Trends Genet.</I> <B>11</B>, 405-411.<!-- HIGHWIRE ID="128:12:2373:7" --><A HREF="/cgi/external_ref?access_num=7482767&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="DIEHL-AND-SHERR-1997"><!-- null --></A>
<P><B>Diehl, J. A. and Sherr, C. J.</B> (1997). A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. <I>Mol. Cell. Biol.</I> <B>17</B>, 7362-7374.<!-- HIGHWIRE ID="128:12:2373:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=17/12/7362" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="DODIG-ETAL-1999"><!-- null --></A>
<P><B>Dodig, M., Tadic, T., Kronenberg, M. S., Dacic, S., Liu, Y. H., Maxson, R., Rowe, D. W. and Lichtler, A. C.</B> (1999). Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. <I>Dev. Biol.</I> <B>209</B>, 298-307.<!-- HIGHWIRE ID="128:12:2373:9" --><A HREF="/cgi/external_ref?access_num=10328922&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="DUBOULE-1995"><!-- null --></A>
<P><B>Duboule, D.</B> (1995). Vertebrate Hox genes and proliferation: an alternative pathway to homeosis? <I>Curr. Biol.</I> <B>5</B>, 525-528.<!-- HIGHWIRE ID="128:12:2373:10" --><!-- /HIGHWIRE --></P>
<A NAME="FANTL-ETAL-1995"><!-- null --></A>
<P><B>Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C.</B> (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. <I>Genes Dev.</I> <B>9</B>, 2364-2372.<!-- HIGHWIRE ID="128:12:2373:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=9/19/2364" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="FANTL-ETAL-1999"><!-- null --></A>
<P><B>Fantl, V., Edwards, P. A. W., Steel, J. H., Vonderhaar, B. K. and Dickson, C.</B> (1999). Impaired mammary gland development in Cyl-/- mice during pregnancy and lactation is epithelial cell autonomous. <I>Dev. Biol.</I> <B>212</B>, 1-11.<!-- HIGHWIRE ID="128:12:2373:12" --><A HREF="/cgi/external_ref?access_num=10419681&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="FRIEDMANN-AND-DANIEL-1996"><!-- null --></A>
<P><B>Friedmann, Y. and Daniel, C. W.</B> (1996). Regulated expression of homeobox genes <I>Msx-1</I> and <I>Msx-2</I> in mouse mammary gland development suggests a role in hormone action and epithelial- stromal interactions. <I>Dev. Biol.</I> <B>177</B>, 347-355.<!-- HIGHWIRE ID="128:12:2373:13" --><A HREF="/cgi/external_ref?access_num=8660900&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="GERSTENFELD-ETAL-1987"><!-- null --></A>
<P><B>Gerstenfeld, L. C., Chipman, S. D., Glowacki, J. and Lian, J. B.</B> (1987). Expression of differentiated function by mineralizing cultures of chicken osteoblasts. <I>Dev. Biol.</I> <B>122</B>, 49-60.<!-- HIGHWIRE ID="128:12:2373:14" --><A HREF="/cgi/external_ref?access_num=3496252&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="GHOSH-CHOUDHURY-ETAL-1996"><!-- null --></A>
<P><B>Ghosh-Choudhury, N., Windle, J. J., Koop, B. A., Harris, M. A., Guerrero, D. L., Wozney, J. M., Mundy, G. R. and Harris, S. E.</B> (1996). Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice. <I>Endocrinology</I> <B>137</B>, 331-339.<!-- HIGHWIRE ID="128:12:2373:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=endo&resid=137/1/331" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="HALL-AND-PETERS-1996"><!-- null --></A>
<P><B>Hall, M. and Peters, G.</B> (1996). Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. <I>Adv. Cancer Res.</I> <B>68</B>, 67-108.<!-- HIGHWIRE ID="128:12:2373:16" --><A HREF="/cgi/external_ref?access_num=8712071&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="HAMBURGER-AND-HAMILTON-1951"><!-- null --></A>
<P><B>Hamburger, V. and Hamilton, H. L.</B> (1951). A series of normal stages in the development of the chick embryo. <I>J. Morphol.</I> <B>88</B>, 49-92.<!-- HIGHWIRE ID="128:12:2373:17" --><!-- /HIGHWIRE --></P>
<A NAME="HU-ETAL-1998"><!-- null --></A>
<P><B>Hu, G., Vastardis, H., Bendall, A. J., Wang, Z., Logan, M., Zhang, H., Nelson, C., Stein, S., Greenfield, N., Seidman, C. E. et al. (</B>1998). Haploinsufficiency of MSX1: a mechanism for selective tooth agenesis. <I>Mol. Cell. Biol.</I> <B>18</B>, 6044-6051.<!-- HIGHWIRE ID="128:12:2373:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=18/10/6044" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="HUGHES-ETAL-1987"><!-- null --></A>
<P><B>Hughes, S. H., Greenhouse, J. J., Petropoulos, C. J. and Sutrave, P.</B> (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. <I>J. Virol.</I> <B>61</B>, 3004-3012.<!-- HIGHWIRE ID="128:12:2373:19" --><A HREF="/cgi/external_ref?access_num=3041020&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="HYNES-ETAL-1990"><!-- null --></A>
<P><B>Hynes, N. E., Taverna, D., Harwerth, I. M., Ciardiello, F., Salomon, D. S., Yamamoto, T. and Groner, B.</B> (1990). Epidermal growth factor receptor, but not c-erb-2 activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells. <I>Mol. Cell. Biol.</I> <B>10</B>, 4027-4034.<!-- HIGHWIRE ID="128:12:2373:20" --><A HREF="/cgi/external_ref?access_num=2196443&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="JABS-ETAL-1993"><!-- null --></A>
<P><B>Jabs, E. W., M&uuml;ller, U., Li, X., Ma, L., Luo, W., Haworth, I. S., Klisak, I., Sparkes, R., Warman, M. L., Mulliken, J. B. et al. (</B>1993). A mutation in the homeodomain of the human <I>MSX2</I> gene in a family affected with autosomal dominant craniosynostosis. <I>Cell</I> <B>75</B>, 443-450.<!-- HIGHWIRE ID="128:12:2373:21" --><A HREF="/cgi/external_ref?access_num=8106171&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="KINSELLA-AND-NOLAN-1996"><!-- null --></A>
<P><B>Kinsella, T. M. and Nolan, G. P.</B> (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. <I>Hum. Gene Ther.</I> <B>7</B>, 1405-1413.<!-- HIGHWIRE ID="128:12:2373:22" --><A HREF="/cgi/external_ref?access_num=8844199&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="KRUMLAUF-1994"><!-- null --></A>
<P><B>Krumlauf, R.</B> (1994). <I>Hox</I> genes in vertebrate development. <I>Cell</I> <B>78</B>, 191-201.<!-- HIGHWIRE ID="128:12:2373:23" --><A HREF="/cgi/external_ref?access_num=7913880&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="LITTLEWOOD-ETAL-1995"><!-- null --></A>
<P><B>Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G. and Evan, G. I.</B> (1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. <I>Nucleic Acids Res.</I> <B>23</B>, 1686-1690.<!-- HIGHWIRE ID="128:12:2373:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nar&resid=23/10/1686" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="LIU-ETAL-1995"><!-- null --></A>
<P><B>Liu, Y. H., Kundu, R., Wu, L., Luo, W., Ignelzi Jr, M. A., Snead, M. L. and Maxson Jr, R. E.</B> (1995). Premature suture closure and ectopic cranial bone in mice expressing <I>Msx2</I> transgenes in the developing skull. <I>Proc. Natl. Acad. Sci. USA</I> <B>92</B>, 6137-6141.<!-- HIGHWIRE ID="128:12:2373:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=92/13/6137" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="MAULBECKER-AND-GRUSS-1993"><!-- null --></A>
<P><B>Maulbecker, C. C. and Gruss, P.</B> (1993). The oncogenic potential of deregulated homeobox genes. <I>Cell Growth &amp; Diff.</I> <B>4</B>, 431-441.<!-- HIGHWIRE ID="128:12:2373:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=cellgd&resid=4/5/431" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="MINA-ETAL-1996"><!-- null --></A>
<P><B>Mina, M., Gluhak, J. and Rodgers, B.</B> (1996). Downregulation of Msx-2 expression results in chondrogenesis in the medial region of the avian mandible. <I>Conn. Tissue Res.</I> <B>35</B>, 79-84.<!-- HIGHWIRE ID="128:12:2373:27" --><A HREF="/cgi/external_ref?access_num=9084645&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="NEWBERRY-ETAL-1997"><!-- null --></A>
<P><B>Newberry, E. P., Boudreaux, J. M. and Towler, D. A.</B> (1997). Stimulus-selective inhibition of rat osteocalcin promoter induction and protein-protein interactions by the homeodomain repressor Msx2. <I>J. Biol. Chem.</I> <B>272</B>, 29607-29613.<!-- HIGHWIRE ID="128:12:2373:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/47/29607" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="NOVEEN-ETAL-1995"><!-- null --></A>
<P><B>Noveen, A., Jiang, T. X., Ting-Berreth, S. A. and Chuong, C. M.</B> (1995). Homeobox genes Msx-1 and Msx-2 are associated with induction and growth of skin appendages. <I>J. Invest. Dermatol.</I> <B>104</B>, 711-719.<!-- HIGHWIRE ID="128:12:2373:29" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jidonline&resid=104/5/711" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="ODELBERG-ETAL-2000"><!-- null --></A>
<P><B>Odelberg, S. J., Kollhoff, A. and Keating, M. T.</B> (2000). Dedifferentiation of mammalian myotubes induced by msx1. <I>Cell</I> <B>103</B>, 1099-1109.<!-- HIGHWIRE ID="128:12:2373:30" --><A HREF="/cgi/external_ref?access_num=11163185&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="PARRY-ETAL-1999"><!-- null --></A>
<P><B>Parry, D., Mahony, D., Wills, K. and Lees, E.</B> (1999). Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. <I>Mol. Cell. Biol.</I> <B>19</B>, 1775-1783.<!-- HIGHWIRE ID="128:12:2373:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=19/3/1775" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="PAVLOVA-ETAL-1994"><!-- null --></A>
<P><B>Pavlova, A., Boutin, E., Cunha, G. and Sassoon, D.</B> (1994). <I>Msx1</I> (<I>Hox-7.1</I>) in the adult mouse uterus: cellular interactions underlying regulation of expression. <I>Development</I> <B>120</B>, 335-346.<!-- HIGHWIRE ID="128:12:2373:32" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=develop&resid=120/2/335" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="PHIPPARD-ETAL-1996"><!-- null --></A>
<P><B>Phippard, D. J., Weber-Hall, S. J., Sharpe, P. T., Naylor, M. S., Jayatalake, H., Maas, R., Woo, I., Roberts-Clark, D., Francis-West, P. H., Liu, Y.-H. et al. (</B>1996). Regulation of <I>Msx-1</I>, <I>Msx-2</I>, <I>Bmp-2</I> and <I>Bmp-4</I> during foetal and postnatal mammary gland development. <I>Development</I> <B>122</B>, 2729-2737.<!-- HIGHWIRE ID="128:12:2373:33" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=develop&resid=122/9/2729" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="POLLOCK-ETAL-1992"><!-- null --></A>
<P><B>Pollock, R. A., Jay, G. and Bieberich, C. J.</B> (1992). Altering the boundaries of Hox3.1 expression: evidence for antipodal gene regulation. <I>Cell</I> <B>71</B>, 911-923.<!-- HIGHWIRE ID="128:12:2373:34" --><A HREF="/cgi/external_ref?access_num=1360875&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="RAO-AND-KOHTZ-1995"><!-- null --></A>
<P><B>Rao, S. S. and Kohtz, D. S.</B> (1995). Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. <I>J. Biol. Chem.</I> <B>270</B>, 4093-4100.<!-- HIGHWIRE ID="128:12:2373:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=270/8/4093" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="REZNIKOFF-ETAL-1973"><!-- null --></A>
<P><B>Reznikoff, C. A., Brankow, D. W. and Heidelberger, C.</B> (1973). Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. <I>Cancer Res.</I> <B>33</B>, 3231-3238.<!-- HIGHWIRE ID="128:12:2373:36" --><A HREF="/cgi/external_ref?access_num=4357355&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SATOKATA-ETAL-2000"><!-- null --></A>
<P><B>Satokata, I., Ma, L., Ohshima, H., Bei, M., Woo, I., Nishizawa, K., Maeda, T., Takano, Y., Uchiyama, M., Heaney, S. et al. (</B>2000). Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. <I>Nat. Genet.</I> <B>24</B>, 391-395.<!-- HIGHWIRE ID="128:12:2373:37" --><A HREF="/cgi/external_ref?access_num=10742104&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SATOKATA-AND-MAAS-1994"><!-- null --></A>
<P><B>Satokata, I. and Maas, R.</B> (1994). <I>Msx1</I> deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. <I>Nat. Genet.</I> <B>6</B>, 348-355.<!-- HIGHWIRE ID="128:12:2373:38" --><A HREF="/cgi/external_ref?access_num=7914451&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SHEN-AND-LEDER-1992"><!-- null --></A>
<P><B>Shen, M. M. and Leder, P.</B> (1992). Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. <I>Proc. Natl. Acad. Sci. USA</I> <B>89</B>, 8240-8244.<!-- HIGHWIRE ID="128:12:2373:39" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=89/17/8240" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="SHERR-AND-ROBERTS-1999"><!-- null --></A>
<P><B>Sherr, C. J. and Roberts, J. M.</B> (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. <I>Genes Dev.</I> <B>13</B>, 1501-1512.<!-- HIGHWIRE ID="128:12:2373:40" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=genesdev&resid=13/12/1501" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="SICINSKI-ETAL-1995"><!-- null --></A>
<P><B>Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J. and Weinberg, R. A.</B> (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. <I>Cell</I> <B>82</B>, 621-630.<!-- HIGHWIRE ID="128:12:2373:41" --><A HREF="/cgi/external_ref?access_num=7664341&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SKAPEK-ETAL-1995"><!-- null --></A>
<P><B>Skapek, S. X., Rhee, J., Spicer, D. B. and Lassar, A. B.</B> (1995). Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. <I>Science</I> <B>267</B>, 1022-1024.<!-- HIGHWIRE ID="128:12:2373:42" --><A HREF="/cgi/external_ref?access_num=7863328&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SMITH-ETAL-1997"><!-- null --></A>
<P><B>Smith, R. C., Branellec, D., Gorski, D. H., Guo, K., Perlman, H., Dedieu, J. F., Pastore, C., Mahfoudi, A., Denefle, P., Isner, J. M. et al. (</B>1997). p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. <I>Genes Dev.</I> <B>11</B>, 1674-1689.<!-- HIGHWIRE ID="128:12:2373:43" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=11/13/1674" >[Abstract]</A><!-- /HIGHWIRE --></P>
<A NAME="SONG-ETAL-1992"><!-- null --></A>
<P><B>Song, K., Wang, Y. and Sassoon, D.</B> (1992). Expression of <I>Hox-7.1</I> in myoblasts inhibits terminal differentiation and induces cell transformation. <I>Nature</I> <B>360</B>, 477-481.<!-- HIGHWIRE ID="128:12:2373:44" --><A HREF="/cgi/external_ref?access_num=1360150&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="STEWART-ETAL-1984"><!-- null --></A>
<P><B>Stewart, T. A., Pattengale, P. K. and Leder, P.</B> (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. <I>Cell</I> <B>38</B>, 627-637.<!-- HIGHWIRE ID="128:12:2373:45" --><A HREF="/cgi/external_ref?access_num=6488314&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="SUZUKI-ETAL-1993"><!-- null --></A>
<P><B>Suzuki, M., Tanaka, M., Iwase, T., Naito, Y., Sugimura, H. and Kino, I.</B> (1993). Over-expression of <I>HOX-8</I>, the human homolog of the mouse <I>Hox-8</I> homeobox gene, in human tumors. <I>Biochem. Biophys. Res. Commun.</I> <B>194</B>, 187-193.<!-- HIGHWIRE ID="128:12:2373:46" --><A HREF="/cgi/external_ref?access_num=7687426&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="WALSH-AND-PERLMAN-1997"><!-- null --></A>
<P><B>Walsh, K. and Perlman, H.</B> (1997). Cell cycle exit upon myogenic differentiation. <I>Curr. Opin. Genet. Dev.</I> <B>7</B>, 597-602.<!-- HIGHWIRE ID="128:12:2373:47" --><A HREF="/cgi/external_ref?access_num=9388774&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="WANG-ETAL-1994"><!-- null --></A>
<P><B>Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A. and Schmidt, E. V.</B> (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. <I>Nature</I> <B>369</B>, 669-671.<!-- HIGHWIRE ID="128:12:2373:48" --><A HREF="/cgi/external_ref?access_num=8208295&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="WIANNY-ETAL-1998"><!-- null --></A>
<P><B>Wianny, F., Real, F. X., Mummery, C. L., Rooijen, M. V., Lahti, J., Samarut, J. and Savatier, P.</B> (1998). G1 phase regulators, <I>Cyclin D1, Cyclin D2</I> and <I>Cyclin D3:</I> up-regulation at gastrulation and dynamic expression during neurulation. <I>Dev. Dyn.</I> <B>212</B>, 49-62.<!-- HIGHWIRE ID="128:12:2373:49" --><A HREF="/cgi/external_ref?access_num=9603423&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="WILKIE-ETAL-2000"><!-- null --></A>
<P><B>Wilkie, A. O. M., Tang, Z., Elanko, N., Walsh, S., Twigg, S. R. F., Hurst, J. A., Wall, S. A., Chrzanowska, K. H. and Maxson, R. E.</B> (2000). Funtional haploinsufficiency of the human homeobox gene <I>MSX2</I> causes defects in skull ossification. <I>Nat. Genet.</I> <B>24</B>, 387-390.<!-- HIGHWIRE ID="128:12:2373:50" --><A HREF="/cgi/external_ref?access_num=10742103&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="WINOGRAD-ETAL-1997"><!-- null --></A>
<P><B>Winograd, J., Reilly, M. P., Roe, R., Lutz, J., Laughner, E., Xu, X., Hu, L., Asakura, T., vander Kolk, C., Strandberg, J. D. et al. (</B>1997). Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. <I>Hum. Mol. Genet.</I> <B>6</B>, 369-379.<!-- HIGHWIRE ID="128:12:2373:51" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=hmg&resid=6/3/369" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="WOLOSHIN-ETAL-1995"><!-- null --></A>
<P><B>Woloshin, P., Song, K., Degnin, C., Killary, A. M., Goldhamer, D. J., Sassoon, D. and Thayer, M. J.</B> (1995). MSX1 inhibits MyoD expression in fibroblast x 10T1/2 cell hybrids. <I>Cell</I> <B>82</B>, 611-620.<!-- HIGHWIRE ID="128:12:2373:52" --><A HREF="/cgi/external_ref?access_num=7664340&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="XU-ETAL-1998"><!-- null --></A>
<P><B>Xu, C., Ji, X., Harris, M. A., Mundy, G. R. and Harris, S. E.</B> (1998). A clonal chondrocytic cell line derived from BMP-2/T antigen-expressing transgenic mouse. <I>In Vitro Cell Dev. Biol. Anim.</I> <B>34</B>, 359-363.<!-- HIGHWIRE ID="128:12:2373:53" --><A HREF="/cgi/external_ref?access_num=9639096&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="YAFFE-AND-SAXEL-1977"><!-- null --></A>
<P><B>Yaffe, D. and Saxel, O.</B> (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. <I>Nature</I> <B>270</B>, 725-727.<!-- HIGHWIRE ID="128:12:2373:54" --><A HREF="/cgi/external_ref?access_num=563524&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --></P>
<A NAME="ZHANG-ETAL-1996"><!-- null --></A>
<P><B>Zhang, H., Catron, K. M. and Abate-Shen, C.</B> (1996). A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. <I>Proc. Natl. Acad. Sci. USA</I> <B>93</B>, 1764-1769.<!-- HIGHWIRE ID="128:12:2373:55" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=93/5/1764" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></P>
<A NAME="ZHANG-ETAL-1997"><!-- null --></A>
<P><B>Zhang, H., Hu, G., Wang, H., Sciavolino, P., Iler, N., Shen, M. M. and Abate-Shen, C.</B> (1997). Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. <I>Mol. Cell. Biol.</I> <B>17</B>, 2920-2932.<!-- HIGHWIRE ID="128:12:2373:56" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=17/5/2920" >[Abstract]</A><!-- /HIGHWIRE --></P>


 
		
        
        
	
	
	
	




 






<BR CLEAR=ALL>




  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>



<A NAME="otherarticles"><!-- null --></A>

<P>
</body></html>